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ABSTRACT 
 
The tomato apoplast is a molecular battle ground for proteases and inhibitors during 
plant-pathogen interactions. The interaction between structurally diverse pathogen-
derived inhibitors (EPIC1, EPIC2B, AVR2 and RIP1) and their target proteases 
(RCR3, PIP1 and C14) is an ideal system to study molecular arms-races. First we 
generated a collection of 52 isoforms of proteases and inhibitors in the pFLAG-ATS 
expression vector for expression in Escherichia coli. We summarise the expression of 
both the proteases and inhibitors and show that the inhibitor proteins were produced 
successfully, unlike the proteases.  
Second we expressed and purified AVR2 on a large scale and show that purified 
AVR2 is capable of inhibiting RCR3 and triggering the Cf2-mediated hypersensitive 
response (HR) in tomato demonstrating that recombinant AVR2 is functional. We 
next implement biophysical and structural biology tools to elucidate the secondary 
and tertiary structure of AVR2. The major findings are that: (i) AVR2 is a beta protein 
determined by circular dichroism (CD) (ii) At apoplastic pH, AVR2 exerts a 
conformational change associated with RCR3 inhibition determined by CD and 
tyrosine fluorescent spectroscopy (iii) AVR2 is a potent inhibitor of papain 
determined by enzyme assay using BODIPY FL casein. 
Attempts to crystallize AVR2 with and without epitope tags and at different 
concentrations and conditions failed, possibly because AVR2 is a heavily charged 
basic protein. Next all 13 lysines and the N-terminus of epitope-tagged AVR2 were 
methylated but no crystals were obtained. This methylated AVR2 still triggers HR in 
Cf2 tomato plants. Preliminary NMR experiments of non-methylated AVR2 showed 
good resolution for future structure elucidation of AVR2.  
Third, we tested four different heterologous expression systems (plant, bacterium, 
insect and yeast) to generate high quantities of active and soluble RCR3. We conclude 
that yeast is the best expression system to produce high amounts of soluble proRCR3 
and proRCR3 is fully converted into mature RCR3 in the presence of reducing agents 
and acidic pH buffer.  
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Finally, we study the role of double cysteine (Cys24, Cys25) in the catalytic site of 
RCR3 which is common to PLCP subclass 6 of plant PLCPs. Using agroinfiltration in 
Nicotiana benthamiana we produced C24A, C25A and C24AC25A mutant RCR3 
proteins and we discovered that (i) Cys25 but not Cys24 is the essential catalytic 
residue labelled by activity-based probe MV201. (ii) Surprisingly maturation of 
RCR3 does not require the catalytic Cys25, indicating that other endogeneous 
proteases activate RCR3. (iii) Proteolytically inactive RCR3 mutants triggers Cf-2-
mediated HR in the presence of AVR2 and (iv) Interestingly, ascorbate enhances the 
activity of the C24A mutant but not wild-type RCR3, suggesting that Cys24 in RCR3 
might have a role in sensing redox potential.  
The autocatalytic activation of proRCR3 produced in yeast combined with the 
maturation of the C25A mutant inplanta suggests that RCR3 can be activated by both 
intramolecular and intermolecular processing. 
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ZUSAMMENFASSUNG 
 
Während einer Infektion wird der Interzellularraum (Apoplast) einer Tomatenpflanze 
zum Kampfplatz zwischen Proteasen und deren Inhibitoren. Die Interaktion zwischen 
strukturell diversen Inhibitoren, die vom Pathogen sekretiert werden (EPIC1, 
EPIC2B, AVR2 und RIP1) und deren Zielmolekülen, wirtseigene Proteasen wie 
RCR3, PIP1 und C14, sind ein ideales Modellsystem um das molekulare Wettrüsten 
zwischen Wirt und Pathogen zu untersuchen. Für diese Studie haben wir zunächst 
einen Datensatz bestehend aus insgesamt 52 Isoformen dieser Proteasen und deren 
Inhibitoren im pFLAG-ATS Expressions system, das zur Expression von Proteinen in 
Escherichia coli geeignet ist, erstellt. In dieser Arbeit fassen wir die Ergebnisse dieser 
Expressionstudie sowohl der Proteasen als auch der Inhibitoren zusammen und 
zeigen, dass die Inhibitoren erfolgreich exprimiert und sekretiert werden konnten, die 
Proteasen dagegen nicht. 
Desweiteren haben wir AVR2 im großen Maße exprimiert und aufgereinigt und 
zeigen, dass unser aufgereinigtes AVR2 ein aktiver Inhibitor ist, da es dazu in der 
Lage ist, RCR3 zu hemmen und die hypersensitive Immunantwort (HR) in Tomaten 
zu aktivieren. Im Weiteren untersuchen wir die Sekundär- und Tertiärstruktur von 
AVR2 mit Hilfe von biophysikalischen und strukturbiologischen Methoden. Unsere 
wichtigsten Ergebnisse zeigen, dass: (i) AVR2 ein Betaprotein ist (gemessen durch 
Zirkulardichroismus (CD)), (ii) AVR2 bei apoplastischem pH eine 
Konformationsänderung auslöst, die mit der Hemmung von RCR3 assoziiert ist 
(ebenfalls gemessen durch CD) und (iii) AVR2 ein wirksamer Inhibitor von Papain 
ist, was durch enzymatische Analysen mit BODIPY FL Casein untersucht wurde. 
Es wurden verschiedene Versuche durchgeführt, AVR2 mit oder ohne 
Epitopenmarkierung und unter verschiedenen Ausgangskonditionen sowie in 
verschiedenen Konzentrationen zu kristallisieren. Diese Versuche waren jedoch nicht 
erfolgreich – vermutlich weil AVR2 ein stark geladenes, basisches Protein ist. Auch 
Methylierung sämtlicher 13 Lysine sowie des N-Terminus von epitopenmarkiertem 
AVR2 konnte keine Kristallisierung auslösen. Methyliertes AVR2 ist jedoch immer 
noch in der Lage, in Tomatenpflanzen, die Cf2 besitzen, eine Immunreaktion 
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hervorzurufen. Erste Ergebnisse einer Kernspinresonanzspektroskopie mit 
unmethyliertem AVR2 erzielten eine gute Auflösung und begründen eine gute 
Ausgangsposition für zukünftige Strukturanalysen mit AVR2. 
Im Folgenden wurden verschiedene heterologe Expressionssysteme (Pflanze, 
Bakterium, Insekt und Hefe) getestet, um eine möglichst effiziente Expression von 
aktivem und löslichem proRCR3 zu erreichen. proRCR3 wird bei saurem pH und in 
der Gegenwart von Reduktionsmitteln zur Gänze in reifes und funktionsfähiges RCR3 
umgewandelt.  
Schließlich untersuchen wir die Rolle des Doppelcysteins im katalytischen Zentrum 
von RCR3, welches der Unterklasse 6 innerhalb der pflanzlichen papainartigen 
Cysteinproteasen (PLCPs) gemein ist. Mit Hilfe von Agrobakterium-vermittelter, 
instabiler Transformation von Nicotiana benthamiana haben wir folgende RCR3-
Varianten produziert: C24A, C25A und C24AC25A. Mit Hilfe dieser Varianten 
konnten wir herausfinden, dass (i) Cys25 nicht aber Cys24 die essentielle, 
katalytische Aminosäure ist, die durch die aktivitätsbasierende Sonde MV201 
markiert wird, (ii) zum Reifungsprozess von RCR3 überraschenderweise das 
katalytische Cys25 nicht benötigt wird, was dadurch zu erklären ist, dass andere 
endogene Proteasen RCR3 aktivieren, (iii) proteolytisch inaktive RCR3-Varianten 
eine Cf2 vermittelte Immunantwort auslösen können und (iv) Ascorbat 
interessanterweise die Aktivität der C24A-Variante, nicht aber von Wildtyp-RCR3 
erhöht, was darauf schließen lässt, dass Cys24 eine Rolle bei der Detektion des 
Redoxpotentials spielt. 
Die autokatalytische Aktivierung von in Hefe produziertem proRCR3 zusammen mit 
dem Reifungsprozess der C25A-Variante in planta deuten darauf hin, dass RCR3 
durch intra- sowie intermolekulare Prozessierung aktiviert werden kann. 
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CHAPTER 1: INTRODUCTION 
 
1.1 The Plant immune system 
Plant pathogens use different strategies to invade the host plant. Nematodes and 
aphids insert a stylet into a plant cell to feed on the nutrients, pathogenic bacteria 
inject proteins into the host cell through the type-III secretion system and many 
oomycetes and fungi use haustoria to invaginate the host cell plasma membrane 
(Jones and Dangl, 2006). To circumvent pathogen feeding, plants have evolved 
sophisticated mechanisms to perceive pathogen attack and trigger effective innate 
immune response by secreting enzymes and small molecules. One such well-
characterized perception mechanism is based on the gene-for-gene hypothesis 
introduced by Flor in the 1940s where plant recognize pathogens by resistance genes 
(R) in plants and their cognate avirulence genes (Avr) in the pathogen (Flor, 1942). 
Pathogen-associated Molecular Patterns (PAMPs) or Microbe-associated Molecular 
Patterns (MAMPs) are recognised by the plant surveillance system that consists of 
receptors that activate an immune response. For instance, a 22-amino acid peptide 
fragment of flagellin (flg22) from bacteria like Pseudomonas syringae induces 
transcription of more than 1100 genes in Arabidopsis thaliana (Chinchilla et al., 2006; 
Felix et al., 1999; Zipfel et al., 2004). This response leads to PAMP-triggered 
Immunity (PTI) (Chisholm et al., 2006; Jones and Dangl, 2006). Successful pathogens 
can avoid PTI through the secretion of effector molecules and this phenomenon is 
called Effector-triggered Susceptibility (ETS) which facilitates the colonization of the 
host. At this juncture, there exists a molecular arms-race or co-evolution of the host 
targets that evade manipulation by the effectors and effectors that adapt to new host 
targets. This adaptation phenomenon results in positive selection for variation of 
residues at the interaction surface of the effector target resulting in diversification of 
effectors and their targets (Misas-Villamil and van der Hoorn, 2008).  
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1.2 Interaction of pathogen-derived inhibitors with proteases in the 
tomato apoplast 
The apoplast of leaves is the first site of pathogen colonization and considered as a 
molecular battle ground during plant-pathogen interactions. The tomato apoplast 
contains seven different proteases – RCR3, PIP1, C14, CYP3, ALP, CatB1 and CatB2 
(Shabab et al., 2008). Although PIP1 and RCR3 are closely related Papain-Like 
cysteine proteases (PLCPs), PIP1 dominates the induced proteolytic activity in the 
tomato apoplast during defense (Shabab et al., 2008). PIP1 is a salicyclic acid-induced 
defense protease. During infection, three unrelated pathogens secrete structurally 
diverse inhibitors to counteract the defense mechanism elicited by proteases in tomato 
(Figure 1-1).  
The first pathogen is Cladosporium fulvum which secretes AVR2, a small protein not 
homologous to any known protein. AVR2 inhibits both RCR3 and PIP1, a close 
relative of RCR3 (Rooney et al., 2005; Shabab et al., 2008; van Esse et al., 2008) 
(Figure 1-1).   
The second pathogen is the oomycete Phytophthora infestans, which secretes EPIC1 
and EPIC2B, two closely related cystatin-like proteins. EPICs are expressed at early 
biotrophic stages during infection of tomato or potato (Haas et al., 2009; Tian et al., 
2007). Similar to AVR2, EPIC1 and EPIC2B inhibit both RCR3 and PIP1 (Figure 1-
1) (Song et al., 2009; Tian et al., 2007) but they have an even higher affinity to the 
C14 proteases of tomato and potato (Figure 1-1) (Kaschani et al., 2010). The C14 
protease carries a C-terminal granulin domain which is similar to the Arabidopsis 
orthologue called RD21 (Yamada et al., 2001). C14-like proteases accumulate in the 
vacuole and in vesicles and can act as a peptide ligase (Hayashi et al., 2001; Wang et 
al., 2008; Yamada et al., 2001). The tomato C14 is an abundant protease and has been 
studied under the names TDI-65, SENU1 and CYP1 and is transcriptionally induced 
by heat, cold, drought and senescence (Schaffer and Fischer, 1988; Schaffer and 
Fischer, 1990). The silencing of C14 proteases in N. benthamiana increases the 
susceptibility to P. infestans (Kaschani et al., 2010).  
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The third pathogen is the bacterial pathogen Pseudomonas syringae which produces 
RIP1, a chagasin-like protein that targets the tomato C14 protease (Figure 1-1) 
(Kaschani and van der Hoorn, unpublished).  
 
 
Figure 1-1: Selective inhibition of secreted PLCPs by structurally unrelated 
pathogen effector molecules in the tomato apoplast 
Three different pathogens; a fungus, an oomycete and bacteria attack tomato. During 
infection there is increased secretion of defense-related PLCPs RCR3, PIP1 and C14. 
The fungus Cladosporium fulvum secretes AVR2 which targets RCR3 and PIP1. 
Interaction of RCR3 and AVR2 triggers a Cf2-mediated HR in tomato carrying the 
Cf-2 resistance gene. The oomycete Phytophthora infestans secretes EPIC1 and 
EPIC2B which inhibits RCR3, PIP1 and C14. The bacterium Pseudomonas syringae 
produces RIP1, which targets C14. Protease-inhibitor interactions are represented 
with black (strong) and grey (weak) lines. Models of RCR3 and PIP1 are based on 
crystal structure of 9PAP and C14 on crystal structure of 1S4V. The catalytic Cys 
(yellow) is in the middle of the substrate binding cleft.     
 
1.3 Tomato - Cladosporium fulvum interaction 
Cladosporium fulvum (syn. Passalora fulva) is a biotrophic pathogen on tomato that 
causes leaf mold disease. Durable resistance against C. fulvum has been a major 
objective for tomato breeders (Joosten and de Wit, 1999; Rivas and Thomas, 2002). 
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During leaf colonization, C. fulvum secretes many low-molecular weight effector 
proteins into apoplast, and several of these proteins like AVR2, AVR4, AVR4E and 
AVR9 function as avirulence (AVR2) determinants on specific tomato genotypes 
mediated by the cognate Cf (C. fulvum) resistance (R) proteins like Cf-2, Cf-4, Cf-4E 
and Cf-9 respectively (de Wit et al., 1997; Joosten and de Wit, 1999; Thomma et al., 
2005). Some additional extracellular proteins (Ecps) like Ecp1, Ecp2, Ecp4 and Ecp5 
trigger HR in tomato lines carrying cognate Cf-Ecp genes (de Kock et al., 2005; 
Lauge et al., 2000).  
Cladosporium fulvum encodes AVR2, a preprotein of 78 amino acids which matures 
into a 58 amino acid protein with eight cysteine residues. AVR2 contains disulphide 
bridges between Cys7-Cys33, Cys12-Cys52, Cys29-Cys43 and Cys 53-57 of which 
the first three bridges (Cys7-Cys33, Cys12-Cys52, Cys29-Cys43) provide a very 
compact and stable structure (Figure 1-2A) (Van't Klooster et al., 2011). It has been 
hypothesised that digestion of this stable structure might be difficult for the 
extracellular plant proteases in the tomato apoplast. The disulphide pattern for AVR2 
is different from that of AVR4 and AVR9 (van den Burg et al., 2003; van den Hooven 
et al., 2001). AVR2 inhibits several tomato Papain-like Cysteine Proteases (PLCPs) 
like RCR3 and PIP1 during infection and supresses the defense proteases important 
for host defense (Shabab et al., 2008; van Esse et al., 2008).  AVR2 targets the 
defense-related protease RCR3 that is required for resistance against the fungus to 
trigger a Cf-2 mediated HR (Figure 1-2B) (Kruger et al., 2002). RCR3 activity is not 
dependent on pH, but inhibition by AVR2 occurs only at acidic pH (Rooney et al., 
2005). Since AVR2 is also an effective inhibitor of the more abundant PIP1, PIP1 is 
thought to be virulence target of AVR2 and RCR3 is thought to act as a decoy to trap 
the fungus into a recognition event in plants carrying Cf-2 receptor protein (Shabab et 
al., 2008; van der Hoorn and Kamoun, 2008) (Figure 1-2). The virulence role of 
AVR2 is demonstrated not only in C. fulvum by RNAi but also using Arabidopsis 
expressing AVR2, which became more susceptible to Botrytis cinerea and 
Verticillium dahlia (van Esse et al., 2008). However, in tomato carrying Cf-2, AVR2 
behaves as an avirulence factor and its recognition requires RCR3
pim
 introgressed 
from L. pimpinellifolium.  
Although the mechanism of AVR2 perception is unknown, structural modifications of 
RCR3 by AVR2 is thought to be triggering Cf2-mediated defense signalling, because 
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(i) a natural variant of RCR3 that occurs in L. esculentum causes Cf2-mediated HR in 
an AVR2-independent manner (Kruger et al., 2002) (ii) inhibition of RCR3 by the 
irreversible inhibitor E-64 does not trigger a Cf-2-mediated HR unlike the inhibition 
of RCR3 by AVR2 (Rooney et al., 2005) (iii) rcr3 mutant which also lacks RCR3 
activity did not trigger HR (Rooney et al., 2005) (iv) AVR2 behaves as a 
uncompetitive inhibitor of RCR3 (Van't Klooster et al., 2011).  
 
Figure 1-2: Disulphide bond pattern in AVR2 and RCR3-AVR2 complex trigger 
Cf-2-mediated defense response. 
(A)AVR2 protein sequence. The amino acid sequence of AVR2 (78 amino acid 
residues), consists of 20 amino acid signal peptide (grey) and the 58 amino acid 
mature AVR2 peptide (violet). The disulphide bridges (black full lines) between the 
cysteine residues (red) (Cys7-Cys33, Cys12-Cys52, Cys29 –Cys43 and Cys53- Cys57 
respectively). The figure was modified and adapted from (Van't Klooster et al., 2011). 
(B)The fungus Cladosporium fulvum secretes AVR2 which targets RCR3 in the 
tomato apoplast. Interaction of RCR3 (blue) and AVR2 (red) is recognised by Cf-2 
receptor protein (green) which triggers a Cf2-mediated HR in tomato carrying the Cf-
2 resistance gene. 
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1.4 Defense-related Papain-like Cysteine Proteases (PLCPs); from 
evolution to mechanism 
RCR3, PIP1 and C14 are PLCPs that belong to family C1A of clan CA in the 
MEROPS protease database (http://merops.sanger.ac.uk) (Rawlings et al., 2006). The 
Arabidopsis genome encodes over 800 proteases which are distributed over almost 60 
families belonging to 30 different clans. PLCPs belong to the family C1 of Clan CA. 
The C1 family can be subdivided into i) apoplastic PLCPs (subfamily C1A) which 
comprises proteases that contain disulphide bridges and accumulate in vesicles or 
vacuole or apoplast and ii) cytoplasmic PLCPs (subfamily C1B) which comprises 
proteases that are located in the cytoplasm and lack disulphide bridges (Rawlings et 
al., 2006). Here, we focus on plant papain-like cysteine proteases (PLCPs) that belong 
to subfamily C1A. Subfamily C1B proteases do not exist in plants and shall not be 
discussed further.  
PLCPs are expressed as pre-proenzyme precursors which contains a signal peptide 
(SP); an auto-inhibitory prodomain or propeptide and a mature catalytic domain 
(Cygler and Mort, 1997; Turk et al., 2000; Wiederanders et al., 2003) (Figure 1-3A, 
left). The SP targets the proteins into the secretory pathway and is removed during the 
translocation into the endoplasmic reticulum (Figure 1-3A, left). The propeptide at the 
N-terminus of the protease acts as an intramolecular chaperone facilitating proper 
folding of the protease and inhibits the protease to prevent premature activity 
(Santamaria et al., 1998; Taylor et al., 1995; Velasco et al., 1994; Wiederanders et al., 
2003). The inactive proenzyme or zymogen undergoes proteolytic processing, 
whereby the prodomain is removed from the N-terminus thereby producing an active 
mature protease (Wiederanders et al., 2003) (Figure 1-3A). PLCPs can be activated by 
other proteases or by autocatalytic processing in the acidic environment, Cathepsin B 
for example, can be activated by both (Turk et al., 2000; Turk et al., 2001).  In some 
proteases like RD21 and C14, a C-terminal granulin domain is also removed by 
processing (Shindo et al., 2012; van der Hoorn et al., 2004; Yamada et al., 2001) 
(Figure 1-3A, right).  The mature proteases are usually 23-30 kDa in size, and the 
catalytic triad consists of Cys-His-Asn where the thiol group of catalytic cysteine 
cleaves peptide bonds in the substrate (Shindo and Van der Hoorn, 2008) (Figure 1-
2B). An additional Cys residue in the catalytic site of subclass 6 of plant PLCPs are 
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thought to have a functional role (Richau et al., 2012). Also RCR3 and PIP1 are some 
of the proteases that contain this double cysteine in the active site. In this thesis, we 
study the potential role of extra cysteine residue (Cys 24) in RCR3. 
 
Figure 1-3:  Maturation and Structure of Papain-Like-cysteine proteases 
(PLCPs) 
(A)Domain structure of the open reading frame of PLCPs subfamily C1A. The PLCP 
gene product contains a signal peptide (SP, grey), an autoinhibitory prodomain 
(prodomain, magenta), a protease domain (protease, dark grey) with catalytic triad 
Cys, His, Asn residues (red) (Left). PLCPs are produced as pre-proprotease which 
converts to the proprotease by removing the SP. The proprotease further activates into 
mature protease by removing the prodomain. Some PLCPs like RD21 and C14, 
contain additional C-terminal extension domain (granulin, dark green, right) (Yamada 
et al., 2001, Shabab et al., 2008). The granulin domain is removed from the 
intermediate protease during conversion into the mature protease. The pre-
proprotease, proprotease are the inactive isoforms of PLCPs. Intermediate and mature 
proteases are active isoforms.  (B)Cartoon model of papain (9PAP) with the alpha-
helix domain (grey, right), beta-sheet domain (blue, left), loops (magenta) and the 
catalytic triad with Cys 25 (yellow), His 159 (red) and Asn 158 (orange). The 
substrate binding cleft is marked in the enzyme (black dotted arrow).  
 
1.5 Molecular-arms race at the plant-pathogen interface 
Selection pressure on the effector-targeted proteases to evade the inhibition and on the 
pathogen-derived effectors to adapt to the new proteases has caused variant residues 
B 
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at the interaction surface of the protease-inhibitor complex. Traces of the molecular-
arms race of the enzyme-inhibitor complexes at the plant-pathogen interface has been 
reviewed with different examples and model (Figure 1-4A) (Misas-Villamil and van 
der Hoorn, 2008).  
Interestingly, the structural models of RCR3 and PIP1 based on papain (9PAP) 
revealed that natural variation in wild tomato resides in amino acids at the surface of 
the protein around the substrate binding groove. In contrast, amino acids located 
inside the protein are under conservative selection (Shabab et al., 2008).  Such 
variation in amino acids on the surface of the protease might affect the interaction or 
inhibition by the pathogen effectors. For example, a naturally occurring N194D 
mutation on the surface of RCR3 prevents inhibition by AVR2 (Figure 1-4B).  This 
selection pressure leads to diversifying selection or molecular arms race paving way 
for evolvement of new enzymes and inhibitors to withstand the selection pressure. 
C14 in wild potato exhibits a pattern of diversifying selection which is not present in 
wild tomato, which correlates with co-evolving plant-pathogen interactions (Kaschani 
et al., 2010). Furthermore, a 3D model of C14–EPICs based on papain (9PAP) and 
cystatin (3IMA) predicted that variant residues in potato C14 are located at the 
putative interaction surface with EPICs (Kaschani et al., 2010; Kaschani and Van der 
Hoorn, 2011). It was proposed that three variant residues (K186ND, T210I, E62Q) in 
C14 might be the result of arms-race at the plant-pathogen interface (Figure 1-4C). 
One of the main objectives of my thesis is to implement structural biology to 
understand the positive selection on defense proteases RCR3 and PIP1. Structural 
biology is essential to understand the mode of inhibition, the evolutionary origin of 
inhibitors and the selective pressures on the interaction surface. 
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Figure 1-4: Selection pressure at the plant-pathogen interface 
(A) Different modes of selective pressure on enzymes to evade inhibition leads to 
adaptations for example surface decoration (A) or loop expansion (B) Subsequent 
inhibitor adaptation may reside in adjustments (C) or the selection of entirely new 
inhibitors (D) Adaptations in both inhibitors and enzymes results in positive selection 
for variance at solvent-exposed residues at the interacting surface. Figure adapted 
from (Misas-Villamil and van der Hoorn, 2008). (B) Front and back side of RCR3 
model based on papain (9PAP), with variant residues found in wild tomato. The 
catalytic residue (yellow), substrate binding groove (black dotted line), position with 
nonsimilar variance and similar variance are indicated in red and blue respectively 
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(Shabab et al., 2008). The naturally occurring N194D variant (orange circle) is 
insensitive to AVR2 inhibition. The figure is modified and adapted from (Shabab et 
al., 2008). (C)Model of C14-EPICs interaction. The EPICs bind to the substrate 
binding groove of C14. Residues in the N-terminus and loops LI and L2 are shown as 
sticks. Polymorphic residues in EPICs are shown in purple. The EPICs may stretch 
into the left (Figure 1-4C, left) or right (Figure 1-4C, right) cavities of non-prime 
substrate binding site of C14. The L2 loop of EPICs may interact with K168ND 
polymorphic site in C14.  The figure was adapted from (Kaschani and Van der Hoorn, 
2011). 
 
1.6 Activity Profiling of PLCPs 
Activity-based Protein Profiling (ABPP) will be frequently used in this thesis to detect 
PLCPs activity and inhibition. ABPP is the use of small reactive molecules called 
Activity-based Probes (ABPs) that react with the active site residues of proteins in an 
activity-dependent manner resulting in a covalent, irreversible bond between the 
probe and the protein (Campbell and Szardenings, 2003). The labelled proteins can be 
detected on protein gels or blots or identified by mass spectrometry. ABPP displays 
activities rather than the abundance of the proteases and is a simple method to 
demonstrate the activities of proteases in complex proteomes.  
ABPP was launched one decade ago by chemical biologists in the field of medicine, 
mainly by the laboratories of Dr. Cravatt (Scripps Institute, San Diego, CA, USA) and 
Dr. Bogyo (Stanford Medical School, CA, USA). This technology was implemented 
in plants by Dr. Van der Hoorn and coworkers initially by monitoring the activities of 
PLCPs in leaf proteomes of Arabidopsis thaliana with the biotin version of DCG-04 
(van der Hoorn et al., 2004). 
ABPs are composed of three major elements: reactive group or warhead, reporter tag 
and a linker. The warhead is often an irreversible inhibitor that acts as a substrate but 
locks the mechanism of the enzyme in the covalent intermediate state. Other warheads 
can be based on reversible inhibitors coupled to photoreactive groups, or suicide 
substrates (Cravatt et al., 2008; Kolodziejek and van der Hoorn, 2010).  Using 
different warheads, probes have been generated for phosphatases, PLCPs, lipases, 
methylesterases, kinases and many other protein families (Cravatt et al., 2008; Evans 
and Cravatt, 2006). The reporter is either biotin for purification and detection or a 
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fluorophore like bodipy or rhodamine for quick detection. Finally, the linker connects 
the reactive group to the reporter tag at an appropriate distance avoiding steric 
congestion between the components. 
Design of DCG-04 and MV201 
In this work, ABPP has been used to monitor the activity of wild-type and mutant 
RCR3 proteins using labelled derivatives of E-64 called DCG-04 and MV201 (Figure 
1-5). E-64 is a promiscuous irreversible inhibitor cysteine protease inhibitor that is 
broadly reactive towards PLCPs (Barrett et al., 1982). DCG-04 is a biotinylated 
derivative of E-64 (Figure 1-5A) (Greenbaum et al., 2000) where MV201 carries 
bodipy and an azide minitag (Figure 1-5B) (Richau et al., 2012) .  
 
Figure 1-5: Activity-based probes; MV201 and DCG-04  
DCG-04 (A) and MV201 (B) have E-64 (red), bodipy reporter tag (green) and biotin 
reporter tag (violet) or an azide minitag (blue). Both ABPs label the thiol group of the 
catalytic cysteine residue of PLCPs in an activity-dependent manner. 
 
1.7 Structure studies on protease-inhibitor complexes 
Structural information on protease-inhibitor complexes will greatly enhance our 
understanding on for (e.g) the perception of AVR2 and the role of variant residues. 
The structure of proteins can be elucidated at two different levels i) determining the 
secondary structure, folding, conformational stability and binding properties of 
protein in solution and ii) determining the tertiary structure of proteins. 
INTRODUCTION 
 
12 
 
Circular dichroism (CD) is an excellent tool for rapidly evaluating the secondary 
structure of proteins. Briefly, circular dichroism measures the differences in the 
absorption of left-handed polarized light versus right-handed polarized light as a 
result of structural asymmetry. An ordered structure results in a spectrum that 
contains both positive and negative signals, while the absence of a regular structure in 
a protein corresponds to zero intensity (Greenfield, 2006). In this thesis, we used CD 
measurements to determine how AVR2 is folded, and if the structure of AVR2 is pH 
dependent. Inhibition of RCR3 by AVR2 but not RCR3 activity is pH-dependent 
because the inhibition was observed only at apoplastic pH (Rooney et al., 2005). 
Hence, we also study the conformational stability of AVR2 at different pH. 
Fluorescence spectroscopy determines the folding and refolding of proteins.  This 
technique is dependent on the content of aromatic amino acids with intrinsic 
fluorescent properties (Tyr, Trp or Phe). The conformational changes exerted by the 
proteins can be monitored by the aromatic residues because of their fluorescent 
properties which are sensitive to their environment when protein folds or unfolds 
(Yan and Marriott, 2003). In the native form, Tyr and Trp have a high quantum yield 
and high fluorescence intensity as they are buried within the core of the protein. 
However, the unfolding of protein could be monitored by the decrease in fluorescence 
intensity when exposed to solvents (Yan and Marriott, 2003). We implemented this 
tool for AVR2 to study if conformational changes in AVR2 were pH- dependent. 
The three-dimensional (3D) structure of proteins can be studied by various methods, 
of which significant applications include Nuclear Magnetic Resonance (NMR) and X-
ray crystallography. NMR and X-ray crystallography remain the standards of 
structure determination.  
NMR provides information on the structural, thermodynamic and kinetic properties of 
proteins. This method has been used for molecular characterization of the 3D 
structure and protein dynamics. In principle, NMR relates to the spinning of 
electrically charged atomic nuclei in the macromolecule or protein with a static 
magnetic field.  This magnetic field makes the spin-states of the atomic nuclei vary in 
energy level and NMR is used to measure this transition in energy at different spin 
state. For example, common NMR active nuclei are 1H, 13C, 15N, 31P, 29Si and 
others. Advancements in NMR have made structural analyses of proteins or protein 
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complexes in 30-40 kDa range more routine (Homans, 2004) unlike the larger 
proteins (greater than 40 kDa). This remains the major limitation of NMR.  
X-ray crystallography is the scattering of X-rays by electrons in the crystallized 
macromolecule. This technique has been used extensively to study the interactions of 
protease-inhibitor complexes like Chagasin-Cathepsin L (Ljunggren et al., 2007), 
Chagasin-Papain (Redzynia et al., 2009), Papain-E64 (Kim et al., 1992; Yamamoto et 
al., 1991), Chagasin-Human Cathepsin B (Redzynia et al., 2008) and  Stefin B-Papain 
(Stubbs et al., 1990).  
The determination of a 3D- structure by X-ray crystallography involves seven 
different steps. 
1. Protein purification: High purity and quantity of the purified protein 
(milligrams) is a prerequisite factor for protein crystallization. Affinity tags 
(His6, GST, MBP) and other genetically engineered fusion cleavage tags 
(TEV, Factor Xa) are employed to facilitate the purification of the protein and 
removing the epitope tags. 
 
2. Protein crystallization: The critical part towards determining the structure of a 
protein is to obtain large and highly diffracting crystals. However during the 
initial screening, mostly small crystals are obtained which requires further 
optimisation to grow them further under suitable conditions. The most often 
employed method of growing protein crystals is vapour diffusion, where the 
protein is present in the well with a lower reagent concentration than the 
reservoir. Water from the protein drop vapourises and ends up in the buffer 
reservoir thereby slowly increasing the supersaturation level for the protein. 
 
3. X-ray diffraction: The protein crystals are mounted and placed on the detector 
under the X-ray beam either at room temperature or mounted frozen in a small 
loop in a stream of liquid nitrogen at 100K. A powerful X-ray accelerator like 
a synchrotron is used to scatter the electrons in the beam. This involves 
measuring a large number of reflection intensities where position of each atom 
in the crystal structure influences the intensities of reflections.  
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4. Data processing: The primary result of an X-ray diffraction experiment is an 
electron density map which represents the distribution of electrons in the 
molecule. The processing of the diffraction data involves many established 
algorithms and software that convert the data into an electron density map. 
 
5. Structure solution and refinement: The quality of the electron density map 
obtained during data processing could be improved by refinement. Refinement 
will improve phases and produce precise and clear maps and thereby 
generating better models using different software and algorithms. 
 
6. Structure analysis: A protein structure with an R-factor below 25% is a good 
model. However at this stage, knowledge of the protein at the biological level 
is necessary to interpret the details in the structure. 
 
7. Deposition in the Protein Data Bank (PDB): The PDB database 
(http://www.pdb.org) is a collection of different protein molecules with and 
without its counterpart ligands. The structure is deposited in the PDB where 
the structure is assigned to a code (e.g. Papain 9PAP).  
 
Key Research questions 
 A natural variant of RCR3 that occurs in Solanum lycopersicum (RCR3lyc) 
causes Cf2- mediated HR in an AVR2-independent manner (Kruger et al., 
2002).  
Is the structure of RCR3
lyc 
different from the RCR3
pim
 structure? 
 
 It was proposed that the inhibition of RCR3 by AVR2 induces a 
conformational change in RCR3 thereby triggering a HR (Kruger et al., 2002). 
Inhibition of RCR3 by the irreversible inhibitor E-64 does not trigger a Cf2-
mediated HR unlike the inhibition of RCR3 by AVR2 (Rooney et al., 2005). 
Is there a conformational change in RCR3 upon AVR2 binding or structural 
change in AVR2?  
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 Inhibition of RCR3 by AVR2 and not RCR3 activity itself is dependent on 
apoplastic pH (Rooney et al., 2005).  
Does apoplastic pH influence the conformation of AVR2 to bind and inhibit 
RCR3? 
 
 It has been reported that AVR2 is a non-competitive inhibitor of RCR3 (Van't 
Klooster et al., 2011) which implies that AVR2 may be an allosteric inhibitor 
that changes conformation of RCR3 upon binding.  
Where is the binding site of AVR2 on RCR3? 
 
 In nature, RCR3, PIP1 and C14 carry variant residues on their surface (Misas-
Villamil and van der Hoorn, 2008). Single variant residues at the surfaces may 
determine outcome of interactions with pathogen-derived inhibitors (Kaschani 
et al., 2010; Kaschani and Van der Hoorn, 2011; Shabab et al., 2008). 
How do variant residues affect the interactions with inhibitors? Why is the 
N194D mutant of RCR3 insensitive to AVR2 inhibition? Are these variant 
residues resulting from a co-evolutionary arms-race? 
 
 PLCPs can be activated both by intramolecular and intermolecular processing.  
How is RCR3 activated? Is the prodomain autocatalytically removed? 
 
 PLCPs of subclass 6 contain plant PLCPs RCR3 and PIP1 that contain a 
double cysteine in the active site (Richau et al., 2012).  
What is the role of the extra cysteine Cys24 in RCR3 or PIP1? 
 
Research Objectives 
The objective of this project is to study protease-inhibitor interactions at the plant-
pathogen interface. To achieve this objective, we will follow the following 
approaches: 
First, a collection of tomato proteases and pathogen-derived inhibitors will be 
generated using a novel secretory expression system (pFLAG-ATS) in E.coli. The 
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protein expression of the proteases and inhibitors will be tested and the protein 
expression level will be optimised to generate sufficient protein quantities. 
Second, from the library, we prioritize RCR3 and AVR2 for large scale protein 
production as they are of primary interest. We show that AVR2 is produced and 
purified in sufficient amount. And RCR3 expression is insufficient in E.coli even after 
further optimisation. Different heterologous expression systems (plant, insect and 
yeast) were tested to produce large, soluble quantities of RCR3. RCR3 produced in 
Pichia will be studied for maturation of the proRCR3 to mature and active RCR3.  
Third, after successful expression of AVR2 in E.coli and RCR3 in Pichia, we test the 
purified recombinant AVR2 for inhibitor activity by ABPP and also determine if 
AVR2 is active in an HR assay to determine if AVR2 is in native conformation. We 
use enzyme assays to show that AVR2 inhibits papain. Finally we implement CD 
spectroscopy and tyrosine fluorescence for secondary structure determination at 
various pH. 
Fourth, we setup the crystallization screens for three variant forms of AVR2 (i) 
untagged AVR2 (ii) FLAG-HIS6-TEV-AVR2 and (iii) methylated FLAG-HIS6-TEV-
AVR2 for three-dimensional (3D) structure determination of protein. 
Finally, we study the role of the double Cys (Cys24 and Cys25) in the active site of 
RCR3 by site-directed mutagenesis, agroinfiltration in Nicotiana benthamiana and 
ABPP. 
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CHAPTER 2: RESULTS 
 
2.1 EXPRESSION OF PATHOGEN-DERIVED INHIBITORS AND 
PLANT   PROTEASES 
2.1.1 Proteases and inhibitors 
To generate a collection of proteases and inhibitors, the pFLAG-ATS expression 
vector system was implemented to clone the pathogen-derived inhibitors (EPIC1, 
EPIC2B, AVR2 and RIP1) and the proteases (RCR3, PIP1 and C14). The strong tac 
promoter (a hybrid of trytophan and lactose promoter) in this vector drives high 
protein expression levels when using IPTG as a de-repressor. The OmpA signal 
sequence translocates the processed and soluble proteins into the periplasm of E.coli 
cells. In addition, pFLAG-ATS encodes an N-terminal FLAG epitope tag, (Asp-Tyr-
Lys-Asp-Asp-Asp-Asp-Lys). Due to the hydrophilic nature, the FLAG peptide will be 
on the surface of the fusion protein and serves as a binding site for anti-FLAG 
antibody for detection and purification of the fusion protein. In addition to the above 
mentioned modifications, we introduced a polyhistidine (His6) epitope tag C-terminal 
to the FLAG epitope as cost-effective measure for purification. We also introduced 
the Ile-Glu-Gly-Arg peptide as a cleavage site for Factor Xa (FXa) processing or the 
Glu-Asn-Leu-Tyr-Phe-Gln-Gly peptide for processing by the TEV protease to remove 
the epitope tags after protein purification which might otherwise hamper the 
crystallization process. To improve the efficiency of TEV cleavage, we also 
introduced a spacer sequence (Asp-Tyr-Asp-Ile-Pro-Thr-Thr) before the TEV 
cleavage site (Figure 2-0A). Hence the recombinant fusion proteins were expressed as 
FLAG-HIS6-FXa-inhibitor/protease or FLAG-HIS6-TEV-inhibitor/protease.  
We generated two different forms of the proteases: with the prodomain (PD) and 
without the prodomain (pd). The importance of the prodomain in protein folding and 
activation has already been explained (see Chapter 1; section 1.4). C14 was generated 
either in the presence or absence of the C-terminal granulin domain. Furthermore we 
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generated catalytic mutants of RCR3, PIP1 and C14 because mutation of the catalytic 
cysteine (Cys25) residue into alanine is necessary to prevent the autocatalytic 
degradation of cysteine proteases (Eakin et al., 1993). In addition to the C25A mutant 
in RCR3 we also generated C24A and the double mutant C24AC25A to study the role 
of the Cys24 (see Chapter 2; section 2.4).  
Following the construction of the plasmids, the proteins were expressed and protein 
accumulation in the medium was analyzed on protein gels with coomassie staining. 
Inhibitors were all detected in the medium in relatively high amounts, and with the 
expected molecular weight (Figure 2-0B). The low expression of EPIC2B could be 
improved by IPTG induction at 28˚C instead of 37 ˚C (data not shown).    
Unfortunately, none of the proteases were detected in the medium (summarized in 
Table 1). We tested protein levels in the soluble cell fraction (SCF), and could only 
detect very low amounts of the proteases (Table 1). However, when the insoluble cell 
fraction (ICF) was dissolved in urea and analysed on protein gel, high amounts of 
proteases were detected (Table 1). Thus all inhibitors were secreted as soluble 
proteins in high amounts but the proteases could not be produced as soluble proteins 
using this E.coli expression system. 
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Figure 2-0: Expression and secretion of N-terminal FLAG-HIS6-FXa /TEV 
fusion proteins. 
(A)Schematic diagram of pFLAG-ATS vector system. The tac promoter (dark grey 
arrow), OmpA signal peptide (SP, blue), FLAG peptide (red), HIS6 tag(green), FXa or 
TEV recognition site (grey) and the inhibitor or protease insert (purple). The PCR 
products of the proteases and inhibitors were cloned into the pFLAG-ATS system as a 
HindIII/XhoI or as HindIII/EcoRI respectively. The scissor represents the cleavage 
site of FXa or TEV proteases to remove the epitope tags. (B) SDS-PAGE analysis of 
the inhibitor proteins secreted into the medium.  Recombinant inhibitors with 
FLAG-HIS6-FXa/TEV epitope tags at the N-terminus were ectopically expressed in 
E.coli. The crude protein extracts were analysed by SDS-PAGE to detect the 
expression level of the proteins (black arrow heads). The numbers below the protein 
gel indicate the theoretical molecular weight of the inhibitors (EPIC1, EPIC2B, 
AVR2 and RIP1) with N-terminal tags. 
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Table1 
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1
Source organism of effector or protease; 
2 
Plasmid library code; 
3
 All proteins are N-
terminally tagged with FLAG and His6 epitope tags, followed by a TEV or Factor Xa 
cleavage site. Proteases were produced with (PD) and without prodomain (pd). In 
addition, Cys residues were mutated (C25A and C24A) and the granulin domain of 
C14 was present (Granulin) or absent (granulin); 
* 
Theoretical molecular weight; 
4
The 
proteins accumulating in the 
a
medium, 
b
soluble cell fraction (SCF) and 
c
insoluble cell 
fraction (ICF). Detection of protein expression is based on western blot analysis using 
anti-FLAG or anti RCR3 antibody using RCR3 expressed in E.coli (ICF) as a control. 
Quantification of proteins by Bradford assay gives a read out for the accumulation of 
protein: > 3mg/ml (+++), < 0.2mg/ml (+), undetected (-) and not determined (ND). 
 
2.2 EXPRESSION, PURIFICATION AND STRUCTURAL 
STUDIES OF AVR2 
2.2.1 Expression and Purification of AVR2 
After confirming the expression of recombinant FLAG-HIS-TEV-AVR2 (pSK 
007.02) in E.coli, we expressed and purified FLAG-HIS-TEV-AVR2 to generate 
large amounts for structural studies. First culture media containing AVR2 was 
precipitated by ammonium sulphate. This technique is often used to concentrate 
protein from a larger volume without affecting the protein structure and can also help 
to remove contaminant proteins. The precipitated FLAG-HIS-TEV-AVR2 was 
dissolved and bound to Ni
2+
-NTA agarose (see Chapter 4; section 4.2.1) and eluted by 
an imidazole gradient. The fractions analyzed on SDS-PAGE showed that nickel 
affinity chromatography yielded FLAG-HIS-TEV-AVR2 with < 70% purity and no 
significant loss (Figure 2-1A, lane 2). 
Since the protein purity is a prerequisite factor in crystallisation experiments, we 
further purified FLAG-HIS-TEV-AVR2 by size exclusion chromatography (SEC) to 
remove high molecular weight (HMW) proteins. Protein separation occurs on the 
basis of molecular size and conformation. Separation is achieved using a porous 
matrix to which the proteins, for steric reasons, have different degrees of access; 
smaller molecules have greater access and larger molecules are excluded from the 
matrix causing HMW proteins to elute first. The chromatogram showed elution of 
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proteins in decreasing order of size and contained a major symmetrical peak that 
corresponds to FLAG-HIS-TEV-AVR2 evident when the protein fractions were 
analysed on the SDS-PAGE (Figure 2-1B, right). Thus, by combining nickel affinity 
chromatography with size exclusion chromatography, we can purify AVR2 to 
homogeneity in high yield. 
 We next confirmed the peptide mass of AVR2 by mass spectrometry (MS). The MS 
measurement was performed in the Proteomics department, Max Planck Institute for 
Plant breeding research (MPIPZ), Cologne. The MS profile showed a single peptide 
peak of 9901.190 Da, close to the expected theoretical mass of 9900.22 Da (Figure 2-
2, left). 
 
 
Figure 2-1: Purified FLAG-HIS6-TEV-AVR2 and confirmation by MS analysis 
(A) Ectopic expression and affinity purification of FLAG-HIS6-TEV-AVR2. 
AVR2 with hexa histidine tag at the N-terminus was ectopically expressed in E.coli, 
and purified using Ni
2+
-NTA agarose matrix by affinity chromatography from the 
ammonium sulphate precipitated culture medium. Coomassie staining shows the 
purity of the eluted protein. (B) Chromatogram of size exclusion chromatography 
(SEC). Affinity purified AVR2 was separated on Hiload superdex 75pg and eluting 
proteins were detected at 280 nm. Fractions A3-B12 corresponding to the major peak 
were analysed on protein gel (upper inset). MS analysis on fraction A7 revealed a 
single molecular weight (MW) of 9901.190 Da, close to the theoretical MW of 
B 
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FLAG-HIS6-TEV-AVR2 (9900.22 Da). The UV absorbance at 280nm is indicated on 
the y-axis and the elution volume is indicated on the x-axis.  
 
2.2.2 Removal of epitope tags from FLAG-HIS6-TEV-AVR2 
All tags, whether large or small, have the potential to interfere with the biological 
activity of a protein, impede its crystallisation, or otherwise influence its behaviour. 
Consequently, it is desirable to remove the purification tag. To remove the fusion tags 
from FLAG-HIS6-TEV-AVR2, we used a highly site-specific cysteine protease, the 
TEV protease from Tobacco Etch Virus (TEV). A construct encoding HIS6-TEV 
protease was provided by Institute for Bioorganic chemistry (IBCH), Poznan, Poland. 
The TEV protease recognises the Glu-Asn-Leu-Tyr-Phe-Gln-Gly in the TEV 
recognition site of FLAG-HIS6-TEV-AVR2 with high efficiency and cleaves between 
the Gln and Gly to remove the tags, leaving a single non-native glycine residue on the 
N-terminus of AVR2 (Figure 2-2A). We produced and purified the HIS6-tagged TEV 
protease in E.coli to cleave the epitope tags. TEV digestion was performed with the 
FLAG-HIS6-TEV-AVR2 for 18 hours at 4˚C followed by nickel- affinity 
chromatography. The 10 kDa signal in the flow through and wash fractions 
corresponded to the untagged AVR2 (Figure 2-2B). However, the HIS6-TEV 
protease, the epitope tag FLAG-HIS6-TEV and uncleaved FLAG-HIS6-TEV-AVR2 
remain bound to the nickel column and was later eluted with a higher concentration of 
imidazole (data not shown). These data demonstrate an efficient and complete 
removal of the purification tags from AVR2. 
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Figure 2-2: TEV digestion of FLAG-HIS6-TEV-AVR2 to remove the epitope 
tags. 
(A) Schematic diagram of cleavage of the epitope tags in recombinant FLAG-HIS6-
TEV-AVR2 by recombinant HIS6-TEV protease. The purified HIS6-TEV protease 
recognises a seven amino acid recognition site (Glu-Asn-Leu-Tyr-Phe-Gln-Gly) in the 
linker region of FLAG-HIS6-TEV-AVR2. The cleavage occurs between Gln and Gly 
removing the epitope tags from AVR2. (B) Cleavage of FLAG-HIS6-TEV-AVR2 by 
His6-TEV protease. 2.5 mg purified FLAG-HIS6-TEV-AVR2 (input) was incubated 
for 18 hours at 4˚C in the presence 200 µg of His6-TEV protease. Nickel affinity 
chromatography was performed with the reaction mixture and the fractions were 
separated by SDS-PAGE and visualised by coomassie brilliant blue staining. The 
digested and unbound AVR2 elutes in the flow through and the His6-TEV protease 
and the epitope tags FLAG-HIS6-TEV were bound to the nickel column. 
 
2.2.3 Purified AVR2 blocks labelling of RCR3 by MV201 
To determine if the purified recombinant AVR2 can bind and inhibit RCR3 protease, 
we applied competitive ABPP using MV201 (Figure 2-3A) (Richau et al, 2012). 
MV201 is a fluorescent derivative of E-64 that irreversibly reacts with the active site 
cysteine residue of PLCPs in a mechanism-dependent manner. Protease activity 
profiling with MV201 was performed with apoplastic fluids (AFs) from Nicotiana 
benthamiana plants agroinfiltrated with Rcr3
pim
 in the presence and/or absence of 
AVR2. The commercially available PLCP inhibitor E-64 was used as positive 
inhibition control. AVR2 blocks labelling of RCR3 demonstrating that purified AVR2 
inhibits RCR3 (Figure 2-3B). 
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Figure 2-3: Structure of MV201 and inhibition of MV201 labelling by purified 
AVR2:(A) MV201 has an epoxide reactive group (red), azide minitag (blue) and a 
bodipy reporter tag (green) that enables detection of signals by fluorescent imaging. 
(B) Apoplastic fluids of N. benthamiana plants transiently expressing RCR3
pim 
AFs 
were preincubated in the presence (+) or absence (-) AVR2 (1 µM) or E-64 (40 µM) 
for 30 minutes and labelled with 2 µM MV201 for four hours. The labelled proteins 
were analysed on protein gels. Detection by fluorescent imaging revealed a 24 kDa 
signal corresponding to mature (M) RCR3
pim 
in the absence of AVR2 and E-64, 
whereas in the presence of inhibitors the signal diminished, indicating that both 
AVR2 and E-64 inhibit RCR3
pim 
activity.  
 
2.2.4 Purified AVR2 inhibits RCR3 and triggers Cf2-dependent HR 
To determine if AVR2 produced in bacteria triggers RCR3/Cf2-dependent HR, we 
infiltrated leaves of Cf2/RCR3, Cf0/RCR3 and Cf2/rcr3-3tomato plants with different 
concentrations of purified AVR2. Infiltration of AVR2 alone and not water or buffer 
triggered HR only in Cf-2/RCR3and not in Cf0/RCR3 or Cf2/rcr3-3 tomato leaves 
(Figure 2-4). We found that 100 nM of AVR2 is sufficient to trigger HR although the 
onset of the response was observed only after five-day post infiltration (5dpi). At 500 
nM and higher concentrations of AVR2, HR was triggered within 1dpi.  
We also observed that the lesion area of 500 nM AVR2 was similar to 1000 and 5000 
nM AVR2. This data demonstrate that the purified AVR2 is active and existed in a 
native conformation because it can trigger RCR3 and Cf2-dependent cell death in 
tomato. 
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Figure 2-4: Purified AVR2 triggers hypersensitive response 
Leaflets of 5-week old Cf-2/RCR3, Cf-0/RCR3 and Cf-2/rcr3-3tomato plants 
(Lycopersicon pimpinellifolium) were infiltrated with purified AVR2 generated in 
E.coli at different concentrations (100, 500, 1000 and 5000 nM). Water and buffer (50 
mM Tris-HCl pH 7.5) were infiltrated as negative controls. HR is observed only in 
Cf2/RCR3 tomato leaves. The infiltrated sectors showing cell death symptoms are 
outlined and the infiltrated solutions indicated. Leaflets were photographed at 5-day 
post infiltration. 
 
2.2.5 AVR2 inhibits papain 
We anticipated that AVR2 could also interact with papain, a well-studied cysteine 
protease from the C1A subfamily. Papain is close to RCR3 in the phylogenetic tree of 
plant PLCPs (Richau et al., 2012) and they presumably also share close homology at 
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the structural level (Shabab et al., 2008). We studied the kinetics of the interaction 
between papain and recombinant AVR2 using green fluorescent casein (Bodipy FL-
casein) as substrate. Hydrolysis of Bodipy FL-casein releases highly fluorescent 
Bodipy FL dye labelled peptides (Figure 2-5A). The increase in fluorescence is 
measured by a fluorescence reader and is proportional to the enzyme activity. In this 
analysis, we used constant papain and substrate concentrations and varying 
concentrations of AVR2 (0.1, 1, 25, 100, 250 µM). At increasing concentrations, 
AVR2 inhibited papain unlike in the absence of the inhibitor. The inhibition observed 
for 1 µM AVR2 was fairly similar to 25, 100 and 250 µM AVR2 suggesting that 
nearly all the binding sites of papain is occupied with AVR2 at a concentration of 1 
µM  (Figure 2-5B top ). It has been reported that papain is rapidly inactivated by E-64 
(Ki=10 µM). Hence E-64 at different concentrations (40, 250, 500 µM) was included 
as positive control. All E-64 concentrations completely inhibit the activity of papain 
(Figure 2-5B bottom). 
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Figure 2-5: AVR2 inhibits papain 
(A) Principle of detecting protease activity using bodipy FL-casein (modified from 
Molecular probes, 2004). Casein labelled with the pH-insensitive green-fluorescent 
BODIPY FL dyes are hydrolysed in the presence of protease, releasing highly 
fluorescent BODIPY FL peptides which can be detected at Ex485/Em530 nm by a 
fluorescence reader. (B) AVR2 inhibits papain. 427.24 nM of papain was 
preincubated in sodium acetate buffer pH 5.0 with different concentrations of purified 
AVR2 (left) or E-64 (right) for 30 minutes. Hydrolysis of 400 nM of Bodipy FL 
casein substrate was measured every two minutes for 74 minutes at 530 nm. The 
fluorescence is plotted on the y-axis as fluorescence (OD530nm) and the time interval 
(minutes) on the x-axis. Each point is an average of two measurements with similar 
results. The experiment was repeated with similar results. 
 
2.2.6 Secondary structure characterization of AVR2 by Circular Dichroism 
After confirming that the purified AVR2 inhibits RCR3 and papain and also triggers 
HR in Cf2/RCR3tomato plants, we used a biophysical approach to investigate the 
secondary structure of purified AVR2. This work was done in collaboration with Dr. 
Mohammed Shabab, Department of Biorganic chemistry, Max Planck Institute for 
Chemical Ecology. It has been previously reported that AVR2 inhibits RCR3 at pH 
4.5-5.5 but not at pH 6.0 or higher (Rooney et al., 2005). Here we investigated if this 
pH-sensitivity is intrinsic to the AVR2 structure. 
Circular dichroism (CD) spectroscopy measures differences in the absorption of left-
handed polarized light versus right-handed polarized light, which arises due to 
structural asymmetry. The absence of regular structure results in zero CD intensity, 
while an ordered structure results in a spectrum which can contain both positive and 
negative signals. The spectrum can be interpreted by the CONTINLL software of 
CDpro package for quantitative estimation of structural elements.  
We used CD spectroscopy (CD) in the far-UV spectral region (190-250 nm) to study 
changes in the secondary structure of AVR2 without epitope tag at pH 4.5, 6.0 and 
7.5. The CD analysis predicts that AVR2 predominantly contains beta sheets. 
Interestingly, overlay of the CD spectra at different pH shows a loss of more than one 
third of the beta sheet structure of AVR2 at pH 7.5 and 6.0 compared to pH 4.5 
(Figure 2-7A, B). Thus, CD analysis predicts a conformational change in AVR2 at 
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acidic pH, resulting in increased beta sheet structure associated with the interaction 
with RCR3. 
 
 
 
Figure 2-6: Beta sheet structure of AVR2 is pH sensitive. 
(A) CD spectra of conformational change in AVR2 at different pH (10 mM acetate 
buffer pH 4.5, or 10 mM phosphate buffer pH 7.5) and low salt (10 mM sodium 
chloride). All solutions contained 122 µg/ml AVR2 without tags. The ellipticity per 
residue (deg.cm
2
.dmol
-1
10
-3
) was plotted on the y-axis against wavelength (nm) 
indicated on the x-axis. (B) Secondary structure of AVR2 at different pH predicted by 
CONTINLL program of CDPro software. The predominant conformational change in 
beta-sheet with the change in pH is highlighted in grey. 
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2.2.7 Tyrosine fluorescence spectroscopy confirms conformational change in 
AVR2. 
AVR2 has two aromatic amino acid residues (Tyr
21
) and (Phe
54
) in mature AVR2 
peptide. To confirm the conformational change exhibited by AVR2 at different pH, 
we used Tyr fluorescence spectroscopy. Phenylalanine was not preferred due to its 
weak fluorescent property. In the native folded state, tyrosine has a low quantum yield 
as this residue is generally located within the core of the protein, whereas in a 
partially folded or unfolded state, tyrosines become exposed to solvent which 
increases the fluorescence.  
In our experiment, the intrinsic fluorescence of Tyr
21
 was monitored at different pH at 
274 nm excitation wavelength. The emission spectra show the sum of two peaks: The 
peak at 303 nm is the expected peak for Tyr fluorescence. This peak increases at 
increasing pH, suggesting that Tyr becomes solvent exposed at higher pH. A second, 
broader peak at 330-350 nm increases from pH 4.5 to 6.5, but then decreases at pH 
7.5. 
This peak is possibly caused by deprotonated or hydrogen-bonded Tyr. Thus Tyr 
fluorescence spectroscopy data show conformational changes in AVR2 at different 
pH similar to CD data.  
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Figure 2-7: pH-dependent conformational change of AVR2. 
Fluorescence spectra of AVR2 (122 µg/ml) incubated at different pH; 4.5 (green), 5.5 
(blue), 7.5 (sap green) and 6.5 (maroon). The tyrosine emission scans at excitation 
274 nm was monitored for change in intrinsic fluorescence. The relative fluorescence 
intensity is plotted against the wavelengths (nm). 
 
2.2.8 Crystallisation screens of AVR2 
Any X-ray structure analysis has to overcome two main obstacles. First, to provide 
sufficient amounts of pure protein and second to obtain well-ordered three-
dimensional crystals. The crystallographic work was done in collaboration with Dr 
Rolf Rose and Dr. Christian Ottmann, Chemical Genomics Centre, Dortmund.  
The quantity of AVR2 was not a limiting factor, so we screened 3840 conditions for  
obtaining crystals of AVR2 with and without the epitope tags. These screening 
conditions with the grid screens systematically evaluate different factors, such as a 
precipitant (salts, polymers and solvents); various AVR2 concentrations and various 
pH values. Our crystallisation attempts of different AVR2 concentrations with and 
without the epitope tags had one of the following outcomes: (i) clear drops and no 
crystals (Figure 2-8A); (ii) phase separation (Figure 2-8B); (iii) amorphous precipitate 
(Figure 2-8C); and (iv) large salt crystals (Figure 2-8D). No protein crystals were 
detected in any of these conditions. These data indicate that AVR2 did not reach the 
nucleation phase as it remained soluble, irrespective of very high concentrations. This 
high solubility of AVR2 is thought to be correlated with the high lysine content (ten 
lysines) in the protein. Next we modified the lysines of AVR2 by reductive 
methylation where the large charged lysine residues are masked with two methyl 
groups (Walter et al., 2006). The reductive methylation process was performed with 
25 mg/ml FLAG-HIS6-TEV-AVR2 protein. The reaction lead to a significant amount 
of precipitated protein and the final recovery was only 11mg/ml after purification by 
size exclusion chromatography.  
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Figure 2-8: Crystallisation screens of AVR2 
Images of crystallization experiments for the four different screening conditions of 
AVR2. 3840 different conditions were tested (various pH conditions and precipitants 
at 18˚C and some at 4 ˚C) in the presence and absence of epitope tags in AVR2. Clear 
drops (A), precipitates (B), phase separation (C) and sometimes salt crystals (D) were 
observed. Specific conditions for the selected picture are shown on the bottom. 
 
Mass spectrometry (MS) analysis was performed with the pre- and post-reaction 
samples of the reductive methylation process to evaluate the extent of lysine 
methylation. The MS data revealed a major peak at 10322.172 Da (Figure- 2-9C) 
which is 420,982 Da more than non-methylated AVR2 (9901.190 Da) (Figure- 2-9D). 
This mass increase corresponds to 30 methylation events (each methyl group is 14 
Da) per AVR2 protein consistent with the presence of one N-terminus and 14 lysine 
residues (Figure- 2-9A) in FLAG-HIS6-TEV-AVR2. Enlargement of the major peak 
shows a series of seven peaks with 14 Da distance. The first peak at 10237.906 Da 
indicates that AVR2 accepted at least 24 methylation events  (Figure- 2-9D). To 
investigate whether reductive methylation affected AVR2 function, we infiltrated 
methylated FLAG-HIS6-TEV-AVR2 and a control FLAG-HIS6-TEV-AVR2 into 
Cf2/RCR3 tomato leaves. Cell death phenotype was observed in both the methylated 
and control samples indicating that the lysine-methylated AVR2 was still recognised 
by RCR3, triggering the Cf2-mediated defense response (Figure 2-9E). This 
methylated FLAG-HIS6-TEV-AVR2 protein was tested in crystallization screens but 
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no crystals were detected. The summary of different crystallization screens of AVR2 
is listed in Table 2.   
 
Figure 2-9: MS analysis and HR assay of Lys-met AVR2  
(A)Sequence of FLAG-HIS6-TEV-AVR2 showing the 13 lysines in blue, bold and the 
epitope tags in color: FLAG (red), HIS6 (green) and TEV recognition site (magenta) 
(B)MS analysis of the non-methylated sample revealed a MW of 9901.190 Da. (C)MS 
analysis of the methylated sample revealed a major peak with MW of 10322.172 Da. 
(D)Closer view of methylated FLAG-HIS6-TEV-AVR2 show different peptide peaks 
with an increase of 14 Da. The numbers indicate the number of methylation events 
(red) (E) Cf2-dependent HR response triggered by methylated FLAG-HIS6-TEV-
AVR2. Leaflets of 5-week-old Cf-2/RCR3 tomato were infiltrated with 1 µM 
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methylated or unmethylated FLAG-HIS6-TEV-AVR2. Leaves were photographed 
five days post infiltration.  
 
Table 2 
 
1
AVR2 with and without the epitope tags or methylated; 
2 
Protein concentration in 
mg/mL; 
3
Number of screening conditions tested for each protein concentration; 
4
Names of ready- made crystallization screens from Qiagen used for screening.    
 
2.2.9 Nuclear Magnetic Resonance (NMR) of AVR2 
Efforts to crystallize AVR2 without the protease were not successful. Hence we 
utilized NMR spectroscopy to determine the structure of AVR2 and also study pH-
dependent structural changes in AVR2. The NMR work was done in collaboration 
with Professor Dr. Marcellus Ubbink, Protein chemistry section, Leiden Institute of 
Chemistry, Leiden University.  
In principle, NMR detects the spinning of electrically charged atomic nuclei in the 
macromolecule or protein with a static magnetic field.  This magnetic field makes the 
spin-states of the atomic nuclei vary in energy level and NMR is used to measure this 
transition in energy at different spin state. Common NMR active nuclei are 1H, 13C, 
31P, 15N and 29Si. An initial measurement of unlabelled untagged AVR2 with proton 
NMR suggested that AVR2 has a rigid structure (data not shown). Next AVR2 protein 
was produced as 15N- labelled form to make a Heteronuclear Single Quantum 
Coherence (HSQC) spectrum of AVR2. IH-15N-HSQC displays N-H bonds that are 
found in the peptide backbone, and in Lys, Arg, Trp, His, Asn, Gln residues. AVR2 
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contains 58 N-H groups in the protein backbone, one N-terminal amino group, 11 
lysines, one arginine, ten glycine, three alanine, five leucine, two proline, eight 
cysteine, three aspartic acid, two valine, two glutamic acid, two serine, one tyrosine, 
one isoleucine, three threonine, two asparagine, one glutamine and one histidine; thus 
59 different N-H bonds. The peaks in the 1H-15N HSQC spectrum disperse well and 
the number is similar to the expected number of N-H bonds. According to NMR 
experts this structure is solvable by NMR. Labelling of AVR2 with 13C to generate 
the 1H-13C spectrum of AVR2 is underway. 
 
Figure 2-10: HSQC spectrum of AVR2. 1H-15N NMR spectrum between 11.0 – 
7.0 ppm of AVR2 labelled with 15N isotope. The chemical shift represented as ppm 
in the axis. Each spot or peak in the spectrum represents each amide in AVR2 protein. 
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2.3 HETEROLOGOUS EXPRESSION OF RCR3 IN DIFFERENT 
EXPRESSION SYSTEMS 
 
2.3.1 Expression in plants (Nicotiana benthamiana) 
Transient expression of genes through infiltration of Agrobacterium tumefaciens 
(agroinfiltration) is a quick and easy method to study genes of interest (Kapila et al., 1997; 
Rossi et al., 1993). The advantage of this expression system is that N. benthamiana is a close 
relative of tomato, and has been reported that RCR3 produced in this system is active and 
inhibited by AVR2 (Rooney et al., 2005). In addition, apoplastic fluids (AFs) contain only 
few endogenous plant proteins, which eases the purification procedure. Therefore, we tested 
RCR3 expression in plants by transient over expression of RCR3 through agroinfiltration of 
Nicotiana benthamiana. 
N. benthamiana leaves of 4-5 week old plants were infiltrated with a mixture in a 1:1 ratio of 
A. tumefaciens cultures carrying the binary plasmid containing either RCR3
pim
or P19 genes 
(Song et al., 2009). P19 expresses a viral suppressor protein that prevents the onset of post- 
transcriptional gene silencing (PTGS) in the infiltrated tissue and allows high level of 
transient protein expression (Voinnet et al., 2000). As negative control, a few leaves were 
infiltrated only with P19 expressing A. tumefaciens cultures. The AFs of the adult leaves 
were extracted in water at five days-post-infiltration (5dpi) and the expression of RCR3 was 
detected and analysed on protein blots using the RCR3 antibody. A 24-kDa signal 
corresponding to mature RCR3 was detected in the AFs from the leaves agroinfiltrated with 
RCR3
pim
 and P19 but not in the leaves agroinfiltrated with P19 alone (Figure 3-1A). 
Comparison of RCR3 detected in the AFs with a known quantity of RCR3 expressed in E.coli 
showed that RCR3 quantity was less than 3 mg/ml in the AFs. Thus, to produce 30 mg RCR3 
needed for crystallisation, we would need to isolate AFs from at least 300 leaves. These data 
indicate that RCR3 production by agroinfiltration is not feasible because of the inadequate 
quantity of RCR3 protein production. 
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2.3.2 Expression in bacteria (Escherichia coli) 
As a second expression system, we tested a secretion system based on plasmid pFLAG-ATS 
in E.coli. Because RCR3 contains three putative disulphide bridges, the E.coli secretion 
system is attractive for the production of secreted eukaryotic proteins because the periplasm 
is an oxidising environment and contains enzymes facilitating the formation and 
rearrangement of disulphide bonds (Missiakas and Raina, 1997). Bacteria carrying pFLAG-
ATS encoding a secreted N-terminal FLAG-HIS6-TEV-tagged RCR3 without prodomain 
(pSK 018.01) were grown and induced with IPTG at different temperatures. Sample aliquots 
of RCR3 protease expressed in medium, soluble and insoluble cell fractions after IPTG 
induction were analyzed by western blotting using RCR3 antibody. 
This analysis revealed that RCR3 cannot be detected in the medium irrespective of the 
induction time and temperature (Figure 3-1B, top). In contrast, large RCR3 quantities were 
detected in the supernatant of the Insoluble Cell Fraction (ICF) but only when the lysed 
bacterial cells were dissolved in 8M urea (Figure 3-1B, bottom). Less than 1.5 mg/L RCR3 
was recovered in the soluble cell fraction (SCF) from the lysed bacterial cells without urea 
treatment (Figure 3-1B, middle). Thus, despite the secretory expression system tested under 
various induction conditions, RCR3 was found to accumulate mostly as insoluble protein 
inside the cells, presumably in inclusion bodies. 
2.3.2.1 Refolding of RCR3 produced in E.coli 
We next tested if we could refold RCR3 from the insoluble cell fraction. Refolding is a 
critical step for proteases with disulphide bridges. The 8M urea fraction containing RCR3 
was diluted 100-fold into the refolding buffer containing arginine to increase the polarity and 
refolding yield, and EDTA to chelate metal ions (D'Alessio K et al., 1999; Hwang and 
Chung, 2002; Kopitar et al., 1996; Tobbell et al., 2002). In addition, a 10:1 ratio of reduced 
and oxidised glutathione in the refolding buffer facilitates efficient refolding and disulphide 
formation. This refolding procedure was performed by dialysis at 4˚C for 20 hours. The 
refolded protease was tested for activity by a casein substrate assay after removing EDTA, 
arginine and the redox components by dialysis. In contrast to RCR3 produced by 
agroinfiltration, RCR3 treated with the refolding buffer did not degrade casein, indicating that 
the refolding of RCR3 failed (data not shown). We next tested a gradient refolding procedure 
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by dialyzing the protease in refolding buffer in which the urea concentration was gradually 
reduced from 8M, 6M, 4M, 2M and 0M. Proteolytic analysis revealed that the activity of 
RCR3 was still 70 fold less in comparison to the RCR3 expressed in the AFs by 
agroinfiltration (data not shown).  
In addition to RCR3, also PIP1 and C14 were difficult to express in the bacterial system. 
Furthermore, prodomain containing RCR3 (pSK 019.01) and the catalytic RCR3 mutant 
(C25A) with and without the prodomain (pSK 026.01 and pSK 025.01) respectively were 
also tested in E.coli but the levels of protein expressions were not different from wild-type 
RCR3 (pSK 018.01). These data indicate that heterologous expression of PLCPs in E.coli 
failed to produce soluble proteases, even though sufficient protein was produced.  
2.3.3 Expression in insects (Spodoptera frugiperda) 
As a third expression system, we tested the baculovirus-mediated expression system. This 
expression system has been used for the production of several mammalian proteases, 
including cathepsins and other papain-like cysteine proteases. The expression of proRCR3 in 
insect cells by the baculo virus system was done in collaboration with Professor Lukas Mach, 
University of Natural Resources and Life Sciences (BOKU), Vienna.   
The transfer vector (Pvt-Bac-His_1) derived from Autographa californica Multiple Nuclear 
Polyhedrosis Virus (AcMNPV) was used for gene expression of proRCR3 in insect cells with 
a co-transfection protocol to initiate the homologous recombination of the transfer vector 
with the viral genome in the insect cells. The transfection of the proRCR3 into viral genome 
was confirmed by microscopic examination where the infected cells appeared larger than the 
uninfected cells and had enlarged nuclei. After expression, proRCR3 in the supernatant was 
purified using Ni
2+ 
affinity matrix. The 37 kDa signal on the coomassie stained protein gel 
indicated proRCR3 expression. However proRCR3 was less than 3 mg/L  (Figure 3-1C). 
These data indicate that this expression system is not suitable to generate large quantities of 
proRCR3 protease. 
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2.3.4 Expression in yeast (Pichia pastoris): 
Finally, the Pichia pastoris expression system was implemented to overcome the 
disadvantages of the other three expression systems mentioned in this chapter and generate 
high yield of the proRCR3 protein. This work was done in collaboration with Dr. Boquian 
Wu, Carlsberg laboratory, Denmark. Yeast systems have been extensively used to express 
papain-like cysteine proteases (Bromme et al., 2004). RCR3 was also expressed in Pichia 
pastoris though in low amounts (Rooney et al., 2005). A major advantage of P. pastoris is its 
low level of secretion of endogenous proteins. The heterologously expressed protein is 
secreted and therefore the only major protein in the medium, which dramatically simplifies 
the purification procedure. Similar to the baculovirus-mediated expression in insect cells, the 
yeast expression system also allows post-translational modifications such as disulphide 
formation, proteolytic processing, and glycosylation.  
The methanol-mediated induction initiated the heterologous expression in the yeast 
PichiaPink
TM
 strain 4 (Invitrogen), which resulted in the production of proRCR3 with a C-
terminal His6 epitope tag. To achieve high protein expression, we maintained the pH of the 
culture neutral or alkaline because acidic conditions can sometimes inititate the activation of 
papain-like cysteine proteases. Following expression, Nickel (Ni
2+
) affinity chromatography 
was implemented to purify proRCR3 from the crude extract. This purified sample was 
analysed by coomassie staining of the protein gel. A high amount of a 37 kDa signal was 
detected indicating a relatively high yield and purity of the secreted proRCR3 (Figure 3-1D).  
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Figure 3-1: Expression of RCR3 in plants, bacteria, insects and yeast. 
(A) RCR3 production in plants:Nicotiana benthamiana plants were agroinfiltrated with 
bacterium construct carrying binary plasmids encoding RCR3 and P19 in the ratio 1:1. 
Apoplastic fluids (AFs) of RCR3 were extracted from the agroinfiltrated leaves at five-day 
post infiltration. Both signals (27 and 24 kDa) reveal mature RCR3 (M). The size difference 
is due to the purification tags on RCR3 expressed in E.coli. The RCR3 protein in the AFs is 
insufficient for large protein extraction although it is less contaminated with the endogeneous 
proteins. (B)RCR3 production in bacteria: E.coli cells expressing RCR3 without 
prodomain (pSK 018.01) were induced with IPTG and grown at different temperatures (18˚C, 
28˚C and 37˚C) and time points (6 and 12 hours). Proteins were extracted from the medium, 
soluble cell fraction (SCF) and insoluble cell fraction (ICF). The western blot analysis using 
anti-RCR3 shows no protein secretion into the medium (top) and high amount of protein in 
the insoluble cell fraction (ICF, bottom) and a low amount in the soluble cell fraction (SCF, 
middle). (C) RCR3 production in insects:The baculovirus transfer vector carrying proRCR3 
was transfected into 2×10
6
 insect cells. The proRCR3 (P) was expressed in the supernatant of 
the culture medium. Coomassie protein gel analysis of proRCR3 elutions (E) after Ni
2+ 
affinity shows 37 kDa secreted protein. However, protein levels are insufficient in 
comparison to 1 and 2µg of BSA used for quantitation. (D) RCR3 production in yeast: 
Expression of P. pastoris strain carrying the transfer vector expressing proRCR3. The 37 kDa 
signal corresponding to the secreted proRCR3 (P) in crude medium (Bp) on the left lane of 
the gel was purified by Ni
2+ 
affinity purification and right lane is pooled eluant (E) containing 
purified proRCR3.  
Table 3 
 
1
Different expression systems for RCR3 protein expression; 
2 
Yield of RCR3 protein 
expressed (mg/L); RCR3 expressed in 
a 
soluble fraction (medium and soluble cell fraction) 
and 
b 
insoluble fraction. Detection of protein expression based on the western blot analysis 
using anti-FLAG and anti-RCR3 antibody. Abbreviations: Apoplastic Fluid (AFs), Soluble 
Cell Fraction (SCF), Insoluble Cell Fraction (ICF).  
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2.3.4.1 Putative Glycosylation sites of the expressed RCR3 in Pichia 
O- and N-linked glycosylations are common post-translational modifications performed by P. 
pastoris (Eckart et al., 1996). Pichia can glycosylate heterologous proteins, even when those 
proteins are not normally glycosylated. Also when the protein is glycosylated in the native 
host, Pichia may not glycosylate it on the same positions (serine or threonine residues). We 
used NetGly 3.1 server software to predict potential glycosylation sites in proRCR3. The 
prediction results suggested 46 putative O-glycosylation sites and one putative N- 
glycosylation site in the proRCR3. However, the N-glycosylation site is present in the 
prodomain of proRCR3, which will be eventually removed during the activation process 
(Figure 3-2A). The apparent MW of 37 kDa for RCR3 produced in P. pastoris suggest no 
significant glycosylation since this is close to the expected molecular weight of native protein 
(37 kDa). Furthermore co-infiltration of proRCR3 together with AVR2 triggers HR only in 
Cf2-RCR3 and not Cf0-RCR3 plants, indicating that RCR3 is functional. MS analysis is 
required to confirm the exact mass.  
 
Figure 3-2: Prediction results of putative O- and N- Glycosylation sites in RCR3 and 
RCR3 is active 
(A)RCR3 protease sequence; prodomain (italics) and protease domain (bold). Putative O-
glycosylation (predicted by NetOGlyc 3.1 Server) sites are shown in green and putative N-
glycosylation (predicted by NetNGlyc 3.1 Server) site is indicated in red. (B) RCR3 produced 
in Pichia triggers HR when co-infiltrated with AVR2 in Cf2-rcr3-3
pim
plants. Fully expanded 
leaves of 5-week old Cf2-rcr3-3
pim
plants were infiltrated with proRCR3, with and without 1 
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µM AVR2. HR is observed only in the proRCR3 co-infiltrated with AVR2. Leaves were 
photographed at five-days post infiltration. 
 
2.3.4.2 Maturation of RCR3 produced in Pichia pastoris 
The propeptide region or prodomain must be removed to generate proteolytically active 
RCR3. Several parameters (reducing agents, pH conditions and incubation time) needed to be 
tested for reproducible processing. ProRCR3 was incubated at 25˚C in different reducing 
agents (DTT and L-cysteine) and at different pH (pH 5.0 and 8.0). RCR3 conversion was 
analyzed at various timepoints (30, 90 and 300 minutes) using protein blot with RCR3 
antibody. 
At 300 minutes, 24 kDa mature RCR3 was detected, when incubated at low pH in the 
presence of reducing agents (Figure 3-2A, red, lanes 2-4). The 37 kDa proRCR3 even 
disappeared at 300 minutes, indicating that the conversion to mature RCR3 is complete. At 
90 minutes, proRCR3 was partially converted mature RCR3, and no mature RCR3 was 
detected after 30 minutes. The conversion to mature RCR3 is absent when proRCR3 is 
incubated at pH 8.0 with reducing agent and also when incubated at pH 5.0 without reducing 
agent suggesting that both the reducing agent and acidic pH are required for the maturation. 
Enzymatic assays with Z-Leu-Arg-AMC as substrate was used to monitor the activation of 
the protease during the maturation process. ProRCR3 in the presence or absence of DTT, 
acidic pH buffer (pH 5.0) or alkaline pH buffer (pH 8.0) was treated with 6.66 µM Z-Leu-
Arg-AMC and the conversion of proRCR3 to mature RCR3 was immediately monitored by 
measuring protease activity at 460 nm. The proRCR3 treated with both DTT and acidic pH 
buffer was activated quickly (Figure 3-2B). In contrast no RCR3 activity was detected if 
RCR3 was incubated at pH 5.0 without DTT or at pH 8.0 with DTT (Figure 3-2B). The 
protein blot analysis also confirms the observation (Figure 3-2B, inset). These data confirm 
that both DTT and acidic pH buffer (pH 5.0) are required and sufficient for the activation of 
proRCR3 into mature RCR3.  
Having established the conditions for activation to mature RCR3, competitive ABPP was 
implemented to determine if the mature RCR3 can be inhibited by AVR2. Labelling of 
mature RCR3 with 2 µM MV201 (bodipy derivative of E-64) in the presence of 1 mM DTT 
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and sodium acetate pH 5.0 reveals a strong 24 kDa fluorescent signal confirming that mature 
RCR3 is proteolytically active (Figure 3-2C). Importantly, labelling of RCR3 is suppressed 
upon preincubation with AVR2 or E-64 (Figure 3-2C). Thus RCR3 produced in yeast is 
active and interacts with AVR2. Suprisingly, when proRCR3 was preincubated with E-64 or 
AVR2 in the presence of reducing agent and acidic pH buffer at 25˚C, the maturation of the 
proRCR3 was blocked (Figure 3-2D). The activation mechanism of proRCR3 is discussed   
(Chapter 1 section 1.3).  
 
Figure 3-3: Maturation of proRCR3 and activity of mature RCR3 
(A)Acidic pH and reducing agent promote maturation/activation of RCR3 in vitro; 
ProRCR3 (P) was incubated with different reducing agents and with different pH buffers at 
25˚C. The protein sample aliquots were taken at different time points (30, 90 and 300   
minutes) to analyse the conversion into mature RCR3 (M), (red arrow heads) by protein blot 
using RCR3 antibody. (B) Protease activity monitors the maturation of RCR3.  ProRCR3 
(P) was incubated with or without 10 mM DTT in the presence of Tris pH 8.0 or sodium 
acetate pH 5.0. 6.66 µM Z-Leu-Arg-AMC (Z: N-carbobenzyloxy-7-Amino-4-
methylcoumarin) was included to monitor the activity of RCR3 by the hydrolysis of the 
substrate measured at Ex 360 nm/Em 490 nm. Protein blot using anti-RCR3 antibody shows 
maturation of proRCR3 only in the presence of DTT and NaOAc pH 5.0 buffer (300 minutes) 
C 
 
D 
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(C) E-64 and AVR2 inhibit RCR3. Mature RCR3 (M) produced in yeast preincubated with 
or without 1 µM AVR2 or 40 µM E-64 for 30 minutes in the presence of 1 mM DTT and 25 
mM sodium acetate pH 5.0 and labelled by MV201 for 4 hours. Labelled proteins were 
detected from protein gels using fluorescent scanning. (D) Maturation of proRCR3 can be 
blocked by AVR2 or E-64. The proRCR3 produced in yeast was incubated in the presence 
or absence of 1 µM AVR2 or 40 µM E-64 in 10 mM DTT and 100 mM sodium acetate pH 
5.0 at 25˚C. Samples were analysed by coomassie protein gel after 90 minutes. 
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2.4 ROLE OF CYS 24 IN THE ACTIVE SITE OF RCR3 
 
2.4.1 A double Cysteine (Cys) in the active site is common in PLCP subclass 6 
Nearly all PLCPs possess the catalytic triad (Cys-His-Asn) of which Cys25 (papain 
numbering) is the main residue responsible for the proteolytic activity of the enzyme. 
Plant PLCPs are subdivided into nine subfamilies (Richau et al., 2012) (Figure 4-1A). 
RCR3 and PIP1 belong to subfamily 6 together with senescence-associated PLCP 
SAG12 from Arabidopsis thaliana. Interestingly, SAG12-like PLCPs are typified by 
carrying an additional Cys residue (Cys24) adjacent to the catalytic cysteine (Cys25). 
This double Cys occurs in 85% of this subfamily but hardly in other families (Figure 
4-1B). Also RCR3 carries a double Cys in the active site. The protease domain of 
RCR3 contains eight cysteine residues of which six cysteines (Cys22, Cys63, Cys96, 
Cys151 and Cys204) form three putative disulphide bridges. Since Cys25 is the 
catalytic cysteine, Cys24 must be an unpaired cysteine. A model of RCR3 using 
papain (9PAP) as a template indicates that both Cys24 and the catalytic Cys25 residue 
are located in the substrate binding groove (Figure 4-1C).  
These observations lead to the hypothesis that Cys24 might have a role in RCR3. To 
investigate the role of Cys24 in RCR3, we generated several mutants of RCR3 
(C24A, C25A and C24AC25A) by substituting the cysteine residues into alanine 
because alanine is electrostatically neutral (Figure 4-1D). 
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Figure 4-1: Occurrence of double Cysteine in RCR3 and other plant PLCPs. 
(A) Phylogenetic tree analysis subclassifies 723 plant PLCPs into nine subfamilies 
(adapted and modified Richau et al., 2011). RCR3 belongs to the subfamily 6 (grey). 
(B)Frequency of the double Cys in the active site of different PLCP subfamilies 
observed in subclass 5 and predominantly (more than 85%) in the subclass 6. 
(C)Schematic diagram of RCR3 mutants. The catalytic triad (Cys-His-Asn) is 
indicated (bold letters, dotted lines). RCR3 mutants C25A (CAWAF), C24A 
(ACWAF) and double mutant C24AC25A (AAWAF) were generated from wild-type 
RCR3 (CCWAF) by site-directed mutagenesis. Proteins were produced by 
Agrobacterium mediated expression in planta (agroinfiltration). The signal peptide 
(SP, green), prodomain (violet), protease domain (blue) and putative disulphide 
bridges (Cys22- Cys63, Cys56-Cys96 and Cys151-Cys204) (red) are indicated. (D)  
Structural model of RCR3 was modelled on papain (9PAP). RCR3 is depicted in gray 
ribbon structure with eight cysteine residues (colored). Cys25 is the catalytic cysteine 
(yellow) and six other cysteine residues (Cys22, Cys56, Cys63, Cys96, Cys151 and 
Cys204) form three putative disulphide bridges (magenta) and Cys24 is the unpaired 
cysteine (blue). The double Cysteine (Cys24 and Cys25) in the catalytic groove is 
indicated (red circle). 
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2.4.2 Maturation of RCR3 does not require catalytic Cys25 
To test the accumulation and activity of mutant RCR3, mutant and wild-type RCR3 
were produced in planta by agroinfiltration of N. benthamiana. The analysis of 
apoplastic fluid (AFs) by protein blot using anti-RCR3 revealed that all mutant 
proteins accumulate as mature proteins (M) similar to wild-type RCR3 (Figure 4-2). 
These data show that the maturation of RCR3 is independent of the Cys25 and Cys24 
residues. We also noted that the level of protein accumulation of C25A and 
C24AC25A proteins was consistently higher than the wild-type and C24A mutant 
(Figure 4-2). 
 
Figure 4-2: Mutant RCR3 proteins accumulate as mature proteins  
Apoplastic fluid (AFs) from N. benthamiana leaves overexpressing wild-type and 
mutant RCR3 were analyzed on protein blot using anti-RCR3. The 24 kDa signal 
shows accumulation of mature (M) RCR3 in all mutants, similar to wild-type RCR3. 
 
2.4.3 Cys25 in RCR3 is the only target of MV201 
To determine if the mutants that accumulate as mature RCR3 are also proteolytically 
active, we labelled apoplastic fluids (AFs) containing wild-type and mutant RCR3 
with MV201, (Figure 1-6B). Interestingly, MV201 did not label C25A and the double 
mutant C24AC25A, suggesting that the catalytic Cys25 is the only residue labelled by 
MV201 and that these mutants are proteolytically inactive (Figure 4-3). In contrast, 
wild-type and C24A mutant RCR3 can be labelled by MV201, but not when the 
samples were pre-incubated with E-64, leupeptin, chicken cystatin or AVR2, 
indicating that the C24A mutant is proteolytically active and sensitive for PLCP 
inhibitors including AVR2. 
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Figure 4-3: MV201 profiling of the catalytic mutants of RCR3. 
Wild-type and mutants RCR3 were agroinfiltrated into Nicotiana benthamiana and the 
apoplastic fluid (AFs) containing the mutant proteins was isolated at five-day post 
infiltration (5dpi) from the leaves. AFs were preincubated for 1 hour with E-64 (50 
µM), leupeptin (50 µM), chicken cystain (10 µM) or AVR2 (1 µM) in the presence of 
1 mM DTT and 25 mM sodium acetate pH 5.0 and labelled with 2 µM MV201 for 
four hours. Proteins were separated on protein gels and analysed by fluorescence 
scanning and western blot with anti-RCR3. Abbreviation: M, mature RCR3. 
 
2.4.4 Proteolytically inactive RCR3 triggers Cf2-mediated HR in the presence of 
AVR2. 
To determine if the RCR3 mutants can trigger a Cf2-mediated hypersensitive 
response (HR), we infiltrated leaves of Cf2/rcr3-3 and Cf0/rcr3-3 tomato plants with 
AFs containing mutant RCR3 together with purified AVR2. Interestingly, all the 
mutants triggered HR only in Cf2/rcr3-3 tomato leaves in the presence of AVR2 and 
not with buffer or water or AVR2 alone or in Cf0/rcr3-3 (Figure 4-4). The HR 
response was observed at 3dpi for all RCR3 mutants indistinguishable from wild-type 
RCR3. The control infiltration of only RCR3 does not mount HR responses. These 
data show that, although the C25A and the C24AC25A mutant proteins are inactive, 
they are still recognised by Cf2 plants when co-infiltrated with AVR2. 
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Figure 4-4: RCR3 mutants trigger Cf2-mediated HR 
AFs containing mutant RCR3 were co-infiltrated with 1 µM AVR2 into leaflets of 5 
week-old Cf2/rcr3-3 tomato plants. The infiltrated sectors showing cell death 
symptom are outlined and the infiltrated proteins indicated. Leaflets were 
photographed at 5 days post infiltration. 
 
2.4.5 Ascorbate enhances activity of RCR3 catalytic mutant C24A 
Cysteine residues may act as redox-sensitive regulatory switches which may regulate 
oxidative signalling in plants. To investigate if Cys24 has any role in redox function 
of the protease, we labelled the wild-type and C24A mutant proteins with MV201 in 
the presence of different redox agents like TCEP, DTT, L-cysteine, ascorbate and 
hydrogen peroxide. We anticipated upregulation of labelling in the presence of 
reducing agents. Surprisingly, ascorbate induces labelling of C24A mutant RCR3 
significantly stronger than WT RCR3 (Figure 4-5). In contrast, DTT, TCEP and L-
Cys induce RCR3 labelling of WT and C24A equally well (Figure 4-5). No labelling 
occurred in the presence of H2O2.  
 
 
RESULTS: Role of Cys 25 in the active site of RCR3 
 
50 
 
Figure 4-5: Upregulated activity of C24A RCR3 mutant in the presence of 
ascorbate  
AFs containing wild-type and C24A RCR3 were labelled with MV201 in the presence 
of 25 mM sodium acetate pH 5.0 and 1 mM redox agents (TCEP, DTT, L-cysteine (L-
cys), ascorbate (Asc) and hydrogen peroxide (H2O2) for 4 hours. Proteins were 
separated on protein gels and detected by fluorescence scanning and western blotting 
using RCR3 antibody. Western blot with anti-RCR3 confirms equal RCR3 protein 
levels. C24A is more labelled than WT in the absence of redox reagents possibly 
because of higher C24A protein levels. 
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CHAPTER 3: DISCUSSION 
 
3.1 Structural Characterization of AVR2 
 
We cloned a collection of 52 isoforms of proteases (RCR3, PIP1 and C14) and 
inhibitors (EPIC1, EPIC2B, AVR2 and RIP1) into the pFLAG-ATS vector for 
expression in Escherichia coli. The inhibitors were successfully expressed in E.coli, 
unlike the proteases. Among the collection of inhibitors, we focussed on AVR2 for 
structural characterization as no known homologous protein of AVR2 has been 
reported so far. Circular dichroism indicates AVR2 is a beta sheet protein and that it 
loses a part of its beta structure during a shift from acidic to neutral pH. Tyrosine 
fluorescence spectroscopy supports this conformational change. This conformational 
change coincides with RCR3 inhibition at apoplastic but not cytoplasmic pH. We also 
show that AVR2 is a potent inhibitor of papain in enzymatic assays. Attempts to 
crystallize AVR2 with and without epitope tags at different concentrations and 
conditions failed, possibly because AVR2 is a heavily charged basic protein. 
However, methylation of the 13 lysine residues and the N-terminus of epitope-tagged 
AVR2 generated no crystals either. Surprisingly, the methylated AVR2 still triggered 
HR in Cf-2 tomato plants. We also show preliminary NMR experiments of AVR2 that 
promises future 3D-structure elucidation of AVR2.  
3.1.1   Escherichia coli is an ideal expression system for pathogen-derived 
inhibitors 
For heterologous expression of proteins, Escherichia coli is generally the first choice 
due to the ease with which it is manipulated and its rapid growth in inexpensive 
media. Alternative systems are usually considered only after the E.coli system has 
been explored (Graslund et al., 2008). Similarly, our results also show that the 
expression of pathogen-derived inhibitors EPIC1, AVR2 and RIP1 in E.coli, 
generated sufficient amounts of the protein without optimisation except for EPIC2B. 
The expression of EPIC2B into the medium was tremendously improved by lowering 
the expression temperature and IPTG concentration. We presume that induction at 
high IPTG concentrations at 37˚C leads to high rates of transcription and translation 
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which resulted in accumulation of EPIC2B in the insoluble cell fraction (inclusion 
bodies) (Pugsley, 1993). Inclusion bodies are common in bacterial cells expressing 
mammalian proteins (Kane and Hartley, 1988; Marston, 1986; Mitraki and King, 
1989). High-level expression of even E.coli proteins itself can result in the 
accumulation of inclusion bodies (Cheng, 1983; Georgiou et al., 1986; Scherrer et al., 
1994; Yoshimura et al., 1993).   
3.1.2   Beta sheet structure of AVR2 is pH sensitive 
The ability of proteins to interconvert between different forms of secondary structure 
can occur due to changes in pH, temperature, detergent, ligand binding, etc and can be 
monitored by Circular Dichroism (CD) and intrinsic fluorescence spectroscopy. The 
estimation of the extent of conformational changes in the secondary structure of 
proteins is important; CD has been frequently used for this purpose (Kelly and Price, 
1997; Pace, 1986). For instance, β-sheet structures can act as a precursor to the 
formation of amyloid fibrils which accompany degenerative diseases such as scrapie, 
bovine spongiform encephalopathy (BSE) and Alzheimer’s disease (Hope et al., 1996; 
Jackson et al., 1999). To monitor the transitions from α-helical to β-sheet structures in 
such proteins and peptides, far UV CD has been an invaluable tool.  
The CONTIN/LL program from the CDPro package (Provencher and Glockner, 1981) 
was used to interpret the CD spectrum information for quantitative estimation of 
structural elements in AVR2. Far UV CD analysis of AVR2 without epitope tags 
indicated that beta sheets are the major structural element in AVR2. CD spectra also 
indicate a conformational change from 37.3% to 63.8% beta sheets of AVR2 when 
lowering pH from 7.5-4.5 (Figure 2-6B). A change in conformation was consistent 
with the inhibition of RCR3 by AVR2, which only occurs at apoplastic pH (pH 4.5-
5.5). It is important to note that the pH shift from 7.5 to 6 did not show significant 
changes.  
To confirm the CD data, we performed intrinsic fluorescence spectroscopy of AVR2. 
Aromatic amino acids are useful indicators of the local environment in proteins and 
also monitor the conformational changes of proteins. AVR2 has two aromatic amino 
acid residues (Tyr
21
) and (Phe
54
) which can be used to study conformational changes 
by monitoring their intrinsic fluorescence. In our study we implemented tyrosine 
fluorescent spectroscopy, because phenylalanine fluorescence is relatively weak. In 
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our study Tyr fluorescence (excitation 274 nm and emission 303 nm) indicated 
conformational change exhibited by AVR2 that correlated with the unfolding of 
AVR2: increasing fluorescence intensity with increasing pH. However we also 
observed a (i) reduced tyrosine 303 nm emission fluorescence at pH 7.5 and (ii)  an 
anomalous tyrosine emission at  330-350 nm inaddition to the normal tyrosine 
emission at 303 nm (Figure 2-7)(Raychaudhuri et al., 2008). This anamolous 
behaviour at wavelength other than 303 nm has also been observed in other tyrosine 
containing and tryptophan free proteins: (e.g) cow adrenodoxin at 331 nm (Lim and 
Kimura, 1980), human serum albumin at 345 nm (Longworth, 1981), parsley 
plastocyanin at 315 nm (Graziani et al., 1974), ocomodulin at 345 nm (MacManus et 
al., 1984), Indian-cobra-venom cytotoxins at 345 nm (Szabo et al., 1978), ceratitus 
histone HI at 325-350 nm (Jordano et al., 1983) and HYPK at around 340 nm 
(Raychaudhuri et al., 2011). Although the origin of this shifted tyrosine emission is 
not fully understood, we can definitely exclude any tryptophan fluorescence because 
only the SP of AVR2 contains a tryptophan residue.  ne possible explanation for the 
330-350 nm emission and reduced 303 nm fluorescence intensity at pH 7.5 could be 
that the pKa value of tyrosine is  10.3. Hence when the Tyr residue is at higher pH, 
there is increased population of ionized and stabilized tyrosine in the excited state due 
to loss of proton from the aromatic hydroxyl group.  This would lead to quenching of 
tyrosine fluorescence and possible local hydrogen bonding, influenced by 
neighbouring charges (Raychaudhuri et al., 2011).  
In summary, the excited state proton transfer from the phenolic hydroxyl group to a 
concluded proton acceptor in the local microenvironment around the tyrosine residue 
may lead to the anomalous intrinsic fluorescence property of Tyr
21 
at 340 nm in 
AVR2. The dynamic equilibrium of this single fluorophor switching between tyrosine 
and tyrosinate forms in a conformation-driven environment may attribute to various 
functional properties of AVR2. Although the chemical origin of the anomaly is still 
unclear, these results unequivocally demonstrate a conformation-determined 
microenvironment of the tyrosine residue in AVR2. 
pH sensitive conformations are not uncommon for effector proteins. For example, 
AvrPto secreted by Pseudomonas syringae exhibits a conformational change during a 
pH gradient inorder to translocate from the bacterial cytoplasm (mildly acidic) into 
the host cell (neutral). This pH gradient is required as folded proteins will not be able 
DISCUSSION 
 
54 
 
to pass through the narrow pilus of the TTSS. Hence unfolding of the effector is 
required for translocation at acidic pH in the pilus. The effector refolds upon delivery 
in the host cytoplasm (Dawson et al., 2009). Similar hypothesis or model could be 
proposed where AVR2 (pI 9.13) encounters a pH gradient during secretion from the 
fungal cell into the acidic apoplast where the effector exhibits a structural change in 
the beta sheets to desirable extent in order to bind and inhibit RCR3 (Figure 5-1).  
The speed and convenience of CD are the main advantage of the technique when 
compared to X-ray crystallography and NMR. However the main limitation of CD is 
that it only provides relatively low resolution structural information. Thus, although 
far UV CD can give reasonably reliable estimates of the secondary structure content 
of a protein, it must be noted that these are overall figures and do not indicate which 
regions of the protein are of which structural type. 
Furthermore although CD spectra and tyrosine spectroscopy indicated structural 
changes in AVR2, these studies do not exclude that addition of interacting proteins or 
molecules can lead to structural changes which are essential for their function (Price 
and Stevens, 1999). For example addition of the competitive inhibitor N-
acetylglucosamine to lysozyme led to large increase in the CD peaks at 285 nm and 
295 nm, characteristic of Trp chains (Glazer and Simmons, 1996). Hence the CD 
analysis with both RCR3 and AVR2 at different pH is required to make further 
biological relevance.  
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Figure 5-1: Model: Translocation of AVR2 via pH gradient accompanying 
conformational changes. 
AVR2 (purple) is secreted by Cladosporium fulvum and passes through the 
endoplasmic reticulum (ER, pH 7.2) (A), the golgi complex (pH 6.0-6.7) (B) and 
through the secretory granules (C) to be released into the apoplast. Upon delivery, in 
the acidic apoplast (D) AVR2 exerts structural change in the beta sheet region (more 
beta sheets). AVR2 binds and inhibits RCR3 (red) at the apoplastic pH (4.5-5.5). 
Percentage conformational change indicated (violet). 
 
3.1.3   NMR spectroscopy can complement X-ray crystallography for AVR2 
structural studies 
Three variants of AVR2 were used in crystallization studies: (i) native wild-type 
AVR2 (58-residue protein), (ii) epitope-tagged AVR2 (89-residue protein) and (iii) 
methylated epitope- tagged AVR2. At first, we screened different concentrations up to 
50 mg/ml AVR2 without epitope tags using 864 conditions. Attempts to crystallize 
AVR2 without epitope tags at different concentrations and conditions yielded mostly 
clear drops and some phase separation and precipitates.  Hence we continued 
screening using AVR2 with epitope tag (FLAG-HIS6-TEV) under 2592 screening 
conditions because fusion tags in some cases provides contacts for crystal formation. 
For example, ph0828 (1v30), a 116-residue protein from Pyrococcus horikoshii was 
crystallized in the presence of His tag, where the His-tagged derivative enhanced 
crystallization unlike the wild-type (Klose et al., 2004).  Apart from the presence 
itself, length of the His tag can be crucial to the crystallization process, as it induces 
additional and important crystal contacts. For instance His5 tag not His6 tag  induced a 
stable conformation of OcDH (Octopine dehydrogenase) by creating crystal contacts 
(Smits et al., 2008). However, there are also few reports on the adverse effects of a 
His tag on the structure-function relationships. In our experiments, both epitope-
tagged and untagged AVR2  did not crystallize. 
From the above crystallization screen results, one could attribute the failure of crystal 
formation to the high pI of AVR2: 9.13 for untagged AVR2 and 8.15 for tagged 
AVR2 caused by eleven lysines. High solubility of AVR2 could destabilize the crystal 
lattice through entrophic effects. Ingeneral lysine residues are predominantly located 
on the surface, with 68% exposed, 26% partly exposed and only 6% buried (Baud and 
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Karlin, 1999). This makes the lysine residues the most solvent-exposed residues in 
proteins. Even in proteins with average lysine content (5.8%), these amino acids 
constitute a large fraction of the surface area because most are solvent-accessible. It 
has been calculated that lysines account on an average for 12-15% of solvent-
accessible surface (DoConte and Chothia, 1999). We addressed the the charge 
problem of increased solubility by reductive methylation. This method was originally 
used as a method of isotope labelling (Means and Feeney, 1968; Rice and Means, 
1971) where free amino groups in primary amines (lysine residues and N- terminus) 
are modified to tertiary amines. This method has enhanced the ability of proteins to 
crystallize and resulted in diffracting crystals for maltooligosyl trehalose synthase 
(Kobayashi et al., 1999), pokeweed antiviral protein-II (Kurinov et al., 2000), myosin 
subfragment-1(Rayment et al., 1993), Cathepsin Z (Saxena et al., 2006) and a ternary 
complex consisting of Yersinia pestis virulence factors YopN, SycN and YscB 
(Schubot and Waugh, 2004). Therefore, in our study we implemented reductive 
methylation to enhance the crystallisability of epitope-tagged AVR2. We observed 
precipitation after methylation of AVR2 and the AVR2 concentration reduced 4-fold. 
Mass spectrometry proved that most AVR2 was completely methylated. We also 
observed a series of ion species 14 Da apart that corresponded to addition of single 
methyl groups (Figure 2-9C, D) and that AVR2 carries at least 24 methyl groups. This 
incomplete methylation is observed frequently and could be due to perished reagents 
(Derewenda and Vekilov, 2006).  
As expected, methylated proteins usually display reduced solubility (Schubot and 
Waugh, 2004). Similarly, our 384 crystallization screen tests of methylated AVR2 
exhibited more precipitates, phase separation and less clear drops suggesting reduced 
solubility of methylated AVR2 unlike non-methylated AVR2. Overall methylation of 
AVR2 did not improve the crystal formation. Interestingly, methylated AVR2 still 
triggered Cf-2-mediated HR in tomato similar to unmethylated AVR2 (Figure 2-9E).  
Van’t Klooster et al (Van't Klooster et al., 2011) showed that AVR2 mutants K20A 
and K17A was still able to trigger a Cf2-mediated HR. In agreement with (Van't 
Klooster et al., 2011) thus stability or functionality of AVR2 was not decreased by 
reductive lysine methylation eventhough the charge of AVR2 was altered. However, 
Lys residues can be important for effector recognition. For instance an effector 
protein PopP2 of Ralstonia solanacearum requires a specific lysine residue to trigger 
DISCUSSION 
 
57 
 
immunity in Arabidopsis by the RRS1-R resistance gene perception (Tasset et al., 
2010).  
Another problem for AVR2 crystallization might be the flexibility of domains or 
polypeptides. Flexibile motions in protein can be reduced or eliminated by binding to 
crystallization chaperones such as chemical inhibitors (Ren et al., 1995) or antibody 
fragments (Iwata et al., 1995). Hence a future strategy is to co-crystallize AVR2 with 
RCR3 to stabilize and improve the contacts in the crystal lattice.  
Although crystallization remains to be the leading method for solving structures of 
macromolecules and their complexes in atomic details, the success rests upon 
obtaining diffraction-quality crystals. At present the success rate remains no more 
than 50% (Canaves et al., 2004; Fogg et al., 2006). NMR spectroscopy, despite its 
protein size limitation can complement x-ray crystallography in structural studies 
(Christendat et al., 2000; Savchenko et al., 2003; Yee et al., 2002). X-ray 
crystallography and NMR studies have shown similar overall structure for cysteine 
protease inhibitors chicken cystatin C (Bode et al., 1988; Dieckmann et al., 1993; 
Engh et al., 1993), cystatin A (Martin et al., 1995) and cystatin B in complex with 
papain (Stubbs et al., 1990) by. 
Although extensive NMR experiments of AVR2 have not been performed, the initial 
15
N-HSQC NMR spectrum of AVR2 indicates that AVR2 is amenable to structure 
determination by NMR spectroscopy (Figure 2-10).  The HSQC spectra indicated 
folded protein and contained well-dispersed peaks of roughly equal intensity and an 
expected number of N-H peaks. These spectra suggested that the process of 
determining the 3D-structure of AVR2 by NMR should be relatively straightforward. 
Hence, the application of both X-ray crystallography and NMR spectroscopy to 
validate the structures independently and also probe a wide range of structural and 
dynamic properties of proteins will produce a better understanding of the biological 
function involved. 
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3.1.4   AVR2 a potent inhibitor of Papain 
Papain is a classic family C1A cysteine protease has been widely used and studied 
both in crystallization and enzymatic studies in complex with inhibitors, small 
peptides etc. Papain is inhibited by chagasin (Ki = 36 pM) (Redzynia et al., 2009); 
RIPI from P. syringae(Ki = 2.13nM) (Shabab et al., 2008), cystatins (Ki = 10
-9
 -10
-11
) 
and chicken cystatin (Kd = 60 fM) (Anastasi et al., 1983; Bjork et al., 1989; Lindahl et 
al., 1988; Nicklin and Barrett, 1984). The Ki in extreme cases can be as low as 10
-14
M 
for the human cystatin C-papain complex (Lindahl et al., 1992). Papain is also 
inhibited reversibly by a series of peptidyl α-keto esters, α-keto amides, α-keto acids, 
and α-diketones (Bendall et al., 1977). Papain is inhibited by methyl 3-(N-
benzyloxycarbonyl-L-phenylalanyl)amino-2-oxopropionate (a dicarbonyl compound; 
Ki = 1 µM) and 3-(N-acetyl-L-phenylalanyl)aminopropanone (a monocarbonyl 
compound; Ki = 1.5 mM) (Bendall et al., 1977). E-64 inhibits papain with (Ki= 
10µM).  Other well-known potent reversible inhibitors for papain are peptidyl 
aldehydes (Ki = 1-46nM) (Bendall et al., 1977; Rich, 1986), leupeptin (Ki = 2nM) 
(Rich, 1986) and peptidyl nitriles (Ki = 6-7µM) (Liang and Abeles, 1987).   
In our study, we show that AVR2 is another potent inhibitor of papain.  Papain 
(9PAP) is very close to RCR3 and PIP1 in phylogenetic tree (Beers et al., 2004) and 
also one of the top hits given by a template search by SWISS-MODEL for RCR3 
sequence (Schwede et al., 2003) And papain from Carica papaya is highly 
homologous (43%) to the 344 amino acids  protein encoded by Rcr3 (Kruger et al., 
2002). We performed inhibition assays for different AVR2 concentrations at constant 
papain and bodipy substrate concentrations. We show that AVR2 begins to inhibit 
papain at 25 µM and completely saturates papain at 250 µM (Figure 2-5A). Although 
we clearly observe an inhibition pattern in the presence of AVR2, we cannot conclude 
the mode of inhibition without Ki values. At 40 µM E-64, most of the binding sites of 
papain are occupied resulting in no activity (Figure 2-5B). 
Van’T Klooster et al reported that AVR2 behaves as an non-competitive inhibitor of 
RCR3 using bodipy-FL casein as substrate (Van't Klooster et al., 2011).  These data 
indicate that AVR2 binds outside the substrate binding site in RCR3. In such non-
competitive inhibiton, the inhibitor reduces the activity of the enzyme upon binding 
but it does not affect the binding of the substrate. It is also possible that PLCPs can 
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undergo a conformational change forced by inhibitor binding as observed in Human 
cathepsin B-Chagasin interaction (Redzynia et al., 2008) .  The occluding loop of 
cathepsin B is differently displaced indicating a large range of movement and 
adoption of a conformation forced by the inhibitor (Redzynia et al., 2008). 
Another phenomenon in kinetics is the correlation of inhibition rate with external 
factors like pH, temperature etc. Interestingly, the Papain-RIP1 interaction increases 
with increased in temperatures (Shabab et al., 2008). Papain also shows different 
Kivalues with the inhibitor Gly-Gly-Tyr (Bzl)-Arg at different pH (Kiof 10 µM at pH 
4.3 and Kiof 150 µM at pH 6.0) (Blumberg et al., 1970). The impact of RCR3-AVR2 
interaction on inhibition constant (Ki) values at different pH should coincide with 
ABPP data (Samali et al., 1999; Shabab et al., 2008) and may be supported by 
conformational changes observed by CD assays and intrinsic Tyr fluorescence 
spectroscopy data. 
The determination of Ki of RCR3 with AVR2, EPIC1 and EPIC2B are planned for 
future experiments. These assays will present a better understanding of the mode of 
inhibition (competitive or uncompetitive), and the relative strength of inhibition. 
 
3.2 Biochemical Characterization of RCR3 
Four different expression systems (plant, bacterium, insect and yeast) were tested for 
high amounts of active and soluble RCR3. We show that Pichia pastoris expression 
system is the best of the four expression systems. Further, we show that the activation 
of proRCR3 produced in yeast into mature RCR3 is triggered by reducing agents and 
acidic pH buffer invitro. This observation indicates that RCR3 can be activated by 
intramolecular processing. However, inhibition of RCR3 maturation by E-64 or 
AVR2 may also support a model of intermolecular processing. Finally we study the 
role of double cysteine (Cys24, Cys25) in the catalytic site of RCR3 which is a 
common feature in subfamily 6 of plant PLCPs. Using agroinfiltration in Nicotiana 
benthamiana we produced C24A, C25A and C24AC25A mutant RCR3 proteins and 
we show that Cys25 but not Cys24 is the essential catalytic residue labelled by 
activity-based probe MV201. Surprisingly, maturation of RCR3 does not require the 
catalytic Cys25, indicating that other endogeneous proteases can activate RCR3 in 
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vivo by intermolecular processing. Further we show that proteolytically inactive 
RCR3 mutants trigger Cf-2-mediated HR in the presence of AVR2. Interestingly, we 
found that ascorbate enhances the activity of the C24A mutant but not wild-type 
RCR3, suggesting that Cys24 in RCR3 might have a role in sensing redox potential.  
3.2.1 Production of high quantities of active, soluble RCR3. 
Several expression systems were tested for producing RCR3. Transient expression of 
genes through agroinfiltration is a quick and easy method to study genes of 
interest(Kapila et al. 1997; Rossi et al. 1993). Especially Nicotiana benthamiana has 
been exploited as an expression host for recombinant proteins of clinical interest 
(Jackson et al., 1999; Price and Stevens, 1999).  This system presents several 
advantages over other plant expression systems, including: (i) short expression time in 
mature leaves tempering the growth interference by the transgene products or the risks 
of toxicity; (ii) production of significant amount of recombinant protein in short time 
(days); (iii) easy recovery of proteins secreted in the apoplast by easy vacuum 
infiltration protocols. Isolation of apoplastic fluids (AFs) is a very simple and elegant 
method to study secreted proteins (Joosten, 2012). The presence of viral suppressors 
further enhances the expression of proteins in Nicotiana benthamianaduring 
agroinfiltration (Voinnet et al., 2003). N. benthamiana has been used for transient 
expression of seven different tomato PLCPs (Shabab et al., 2008) and ten Arabidopsis 
PLCPs (Richau et al., 2012). Since RCR3 is present in the apoplast, we agroinfiltrated 
N. benthamiana leaves to produce RCR3 inplanta. Even though the protein was 
soluble, active and relatively pure due to low endogeneous proteins in the apoplast, 
we found that only low amounts of RCR3 was present in the apoplast (Figure 3-1A). 
The < 3 mg/ml RCR3 in AF from 40 leaves is sufficient for labelling experiments and 
other biological assays but not for structural biology studies where milligrams of pure 
protein are required.   
We next tested the E.coli system for the production of RCR3. The first plant proteases 
successfully expressed and produced in high quantities in E.coli were papain (Taylor 
et al., 1995) and caricain (Revell et al., 1993). Later also mammalian cathepsins such 
as cathepsin X (Santamaria et al., 1998), cathepsin O (Velasco et al., 1994), cathepsin 
S (Kopitar et al., 1996; Tobbell et al., 2002), cathepsin L (Barlic-Maganja et al., 1998; 
Dolinar et al., 1995), cathepsin K (D'Alessio K et al., 1999; Hwang and Chung, 2002) 
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and cathepsin B (Kuhelj et al., 1995) have been produced in E.coli. However, in each 
case the protease was produced in inclusion bodies and refolded back into an active 
protein. Similarly, we show that the expression of RCR3, PIP1 and C14 in different 
isoforms in E.coli accumulated in high quantities in the insoluble fraction even though 
a secretion system was used. RCR3 could not be refolded in sufficient quantities. 
Likewise, Cathepsin S was expressed without its prodomain but with a low yield 
when compared with the expression of the proenzyme (Tobbell et al., 2002). Similar 
results were observed with Cathepsin L (Kelly and Price, 1997). One exception is 
falcipain-2, which requires only the additional  N-terminal folding domain but not the 
prodomain for proper folding (Pace, 1986). From the knowledge obtained from the 
above mentioned research, we produced RCR3 with and without the propeptide.  
However, refolding is the most critical step after producing PLCPs in E. coli. We 
initially implemented the refolding of RCR3 by rapidly diluting the denatured protein 
directly into the refolding buffer (Maeda et al., 1995) . Such a dilution refolding 
method has been used for example mild removal of urea from denatured lysozyme by 
dialysis effectively renatured the protein. However, this dilution method did not 
restore RCR3 activity. Protein aggregation at relatively high protein concentration can 
be suppressed by a linear decrease in urea concentration (Yoshii et al., 2000). We 
therefore used a modified gradient refolding protocol used for falcipain (Singh et al., 
2006). Falcipain, like RCR3, belongs to subfamily C1A of PLCPs. The resulting 
RCR3 fractions showed an increase in proteolytic activity when the denaturant was 
decreased (4M to 0M). However,  gradiently refolded RCR3 degraded casein 100-fold 
less than RCR3 expressed inplanta. The low activity of RCR3 both with and without 
the prodomain after refolding could be due to scrambled disulphide bridges and/or 
improper associations with correct domains in the protein.  
We next tested the baculovirus expression system. This system has been used for 
production of large quantities of various parasite-derived and mammalian PLCPs 
(Giancotti et al., 1980; Hammerschmidt, 2010; Lohaus et al., 2001). Insect cells allow 
post-translational modifications similar to mammalian cells. Human cathepsin B 
(Hammerschmidt, 2010) and cathepsin C (Cheng, 1983) have been successfully 
produced in the insect cells. However a distinct disadvantage for expression of 
cysteine proteases in insect cells is the expression of several endogeneous cathepsin-
like proteases like cathepsin B which might interfere in the analysis of the 
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recombinant protease (Bromme and Okamoto, 1995).  We used baculovirus 
expression vectors in insect cells for the production and processing of proRCR3. 
Unlike the successful production of cathepsins and other cysteine proteases mentioned 
above, proRCR3 was secreted only in micrograms per liter culture, indicating that the 
insect cell expression system is not an ideal system for RCR3 expression (Figure 3-
1C). 
We next tested the Pichia pastoris expression system for expression of proRCR3. 
P.pastoris expression system has been successfully used to produce highly disulphide 
bonded proteins (White et al., 1994). The reducing environment of the cytoplasm 
renders prokaryotic expression systems less successful for production of disulphide-
bonded proteins as there is a necessity to refold disulphide-bonded proteins from 
inclusion bodies, or to secrete the proteins into the periplasmic space. A specific 
additional advantage of the P. pastoris expression system is a very low secretion of 
endogeneous proteins, causing the recombinant protein being the major protein in the 
media, which dramatically simplifies the purification procedure (Cregg et al., 1993).   
This espression system has been used for the production of recombinant PLCPs like 
human cathepsin L and X (Carmona et al., 1996; Khouri et al., 1991; Nagler et al., 
1999), cathepsin B from Leishmania major(Chan et al., 1999), cathepsin B2 from 
Schistosoma mansoni(Caffrey et al., 2002) and cathepsin L from Camellia 
sinensis(Park et al., 2001) and also RCR3 (Rooney et al., 2005; Van't Klooster et al., 
2011).  
We found large quantities of proRCR3 (50 mg/L) and low endogenous proteins in the 
medium, making proRCR3 the predominant protein which facilitated an easy 
purification (Figure 3-1D). In P. pastoris, unintended glycosylation is a concern since 
it is a common post-translational modification (Eckart and Bussineau, 1996). It is 
possible that Pichia glycosylates heterologous proteins, even when those proteins are 
normally not glycosylated by the native host. When the protein is glycosylated in the 
native host, Pichia may glycosylate the protein not on the same residues (Cereghino 
and Cregg, 2000). The extent of O-glycosylation by P. pastoris has been studied on 
the catalytic domain of glucoamylase from Aspergillus awamori(Heimo et al., 1997). 
The molecular weight of this protein was 20 kDa heavier when expressed in P. 
pastoris, when compared to the native protein. About 10 kDa of this weight could be 
attributed to N-glycosylation, and the rest was attributed to O-linked glycosides 
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(Heimo et al., 1997). When used as pharmaceuticals, Pichia-derived glycosylated 
proteins have the potential to trigger inappropriate immune responses. For example, 
O-glycosylation near the reactive site of recombinant human antithrombin III resulted 
in a recombinant protein exhibiting only half the inihibitory activity against thrombin 
when compared to the native protein (Mochizuki et al., 2001). Although bioinformatic 
analysis revealed 46 putative O-glycosylation sites and one N-glycosylation site in 
proRCR3, the molecular weight (MW) of proRCR3 was close to the expected MW 
(Figure 3-2A). Furthermore, RCR3 expressed in yeast was functional in the HR assay 
(Figure 3-2B) and in AVR2 inhibition assays (Figure 3-3C). However, MS analysis is 
required to confirm the exact mass upon expression in Pichia.  
 
3.2.2 Intramolecular and Intermolecular processing of proRCR3 
Similar to most other proteases, RCR3 is synthesized as inactive precursor or 
zymogen containing N-terminal propeptide. RCR3 is activated by proteolytic removal 
of the propeptide. The 3D structures of procathepsin L (Coulombe et al., 1996), rat 
procathepsin B (Cygler et al., 1996), procaricain (Groves et al., 1996), human 
procathepsin S (Kaulmann et al., 2006) and human procathepsin K (LaLonde et al., 
1999) reveal that despite having a low homology in their protein sequence,  the 
propeptide adopts a specific structural conformation that is conserved between 
propeptides of the PLCP family. Previous reports suggest that a conformational 
change in the propeptide domain is triggered by acidic pH, resulting in an 
intermediate state which reduces the association affinity towards the protease domain, 
leading to prodomain cleavage and resulting in a mature active enzyme (Gutierrez-
Gonzalez et al., 2006). Processing of PLCPs is therefore thought to occur 
autocatalytically at acidic pH (Bromme et al., 2004). For example, recombinant 
propapain was one of the first cysteine protease precursors successfully activated as 
invitro at pH 4.0 under reducing conditions (20 mM cysteine) and elevated 
temperature (60˚C) (Vernet et al., 1991). Because mutation of the active site C25S in 
papain prevented the processing reaction, this activation was suggested to be initiated 
and to proceed intramolecularly.  We observed a similar type of activation in the 
processing of proRCR3. A time course experiment for processing of proRCR3 
expressed in Pichia(Figure 3-3A, B) shows that recombinant proRCR3 can be 
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activated at acidic pH and reducing conditions, mimicking the environment of the 
endosomal/prelysosomal compartments (Figure 3-3A, B). Low pH and reducing 
conditions may induce a structural transition required for intramolecular cleavage, 
similar to the one described during processing of pepsinogen to pepsin (Glick et al., 
1989). The results described above are consistent with the hypothesis that the 
propeptide processing occurs intramolecularly.  However, in vitro processing of the 
C25A catalytic mutant of RCR3 is required to confirm the mechanism of 
intramolecular processing. This requires the expression of C24A, C25A and 
C24AC25A mutants in Pichia.   
However, we also found evidence for intermolecular processing. The first reason we 
observe is that in vitro removal of propetide from RCR3 can be inhibited by E-64 or 
AVR2 (Figure 3-3C, D). Since the active site is not accessible for E-64 in 
proproteases this observation suggests that one mature protease could trigger a chain 
reaction by intermolecular processing. Inhibition of the mature protease could 
therefore block the activation. Such mechanism has also been proposed for cathepsin 
B: one mature protease can activate the others in a chain reaction creating a positive 
feedback loop (Turk et al., 2000). A second observation supporting intermolecular 
processing is that the catalytic mutants C25A and C24AC25A accumulated as mature 
proteases upon agrofiltration (Figure 4-2).A similar observation was made for the 
RD21 protease of Arabidopsis. These observations imply that the catalytic cysteine is 
not required for removal of prodomain in planta. The accumulation of mature RCR3 
mutants in N. benthamiana could be because other endogenous proteases in the 
lysosomal/ endosomal compartments process RCR3. Proteolytic cascades have not 
been described in plants but are common in animals (Mason and Joyce, 2011). RD21 
catalytic mutant C161A accumulates as processed RD21 even though the mutant was 
inactive in DCG-04 labelling and rubisco degradation (Gu et al., 2012). 
In future experiments, we aim to to use class specific inhibitors to identify the 
endogenous protease. A similar method was used to identify proteases in the 
activation of procathepsins B, H and L (Nishimura et al., 1989; Nishimura et al., 
1988; Wiederanders and Kirschke, 1989). To determine the subcellular localization of 
activation of the proteases in plants, the secretory pathway inhibitor brefeldin can be 
used. This exocytosis inhibitor was used to demonstrate that cathepsin B is processed 
during secretion (Gilroy et al., 2007). 
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 In summary our study implies that proRCR3 can be processed by both intramolecular 
and intermolecular processing. This mechanism is similar to recombinant 
procathepsin L where both intra- and intermolecular reactions might be involved 
(Mach et al., 1994; McDonald and Emerick, 1995; Nomura and Fujisawa, 1997).  
 
3.2.3 Role of double cysteine in active site of RCR3 – Cys24 as redox sensor? 
In this study we set out to investigate the role of Cys24 in the active site of PLCPs in 
subfamily 6. We speculate that the unpaired Cys24 has a functional relevance and 
hence we focused on RCR3 mutants for our study. In proteins, cysteine is the most 
intrinsically nucleophilic amino acid and its reactivity is tuned to perform diverse 
biochemical functions. During initial studies, we hypothesized that this extra cysteine 
may act as an alternative catalytic cysteine or as a redox sensor (Richau et al., 2012).   
We presumed that Cys24 might either perform a catalytic role together or in the 
absence of Cys25. Hence we expressed different RCR3 mutants (C24A, C25A and 
C24AC25A) proteins in planta and tested the mutants for MV201 labelling in the 
presence or absence of different  inhibitors. We detected labelling of a 24 kDa signal 
corresponding mature RCR3 only in the wild-type and C24A and this signal was 
competed in the presence of inhibitors (Figure 4-3). This observation implies that 
Cys25 is the only target of MV201. We conclude that C25A and C24AC25A mutants 
are proteolytically inactive. Interestingly, all the RCR3 mutants triggered HR in the 
presence of AVR2 in Cf2/rcr3-3 tomato (Figure 4-4). These data demonstrate that the 
mutations did not abolish AVR2/Cf2 recognition in tomato. We also observed that the 
C25A and C24AC25A mutants accumulated as mature forms upon agroinfiltration. 
Enzymatic assays with the RCR3 mutants using bodipy casein as substrate did not 
work because of endogenous proteins in AFs even in the P19 control. To produce 
purified RCR3 mutant proteins, the expression of C24A, C25A and C24AC25A 
mutants in Pichia are planned for future experiments. We next explained if the Cys24 
has a role in redox regulation in plants. We observed that H2O2 prevented the labelling 
of RCR3 wild-type and mutant C24A using MV201. This observation is in agreement 
with (Borutaite and Brown, 2001) where H2O2 inactivates caspases and DTT could 
reverse the H2O2-induced inactivation. All reducing agents activate both wild-type 
and C24A. Interestingly, ascorbate activates C24A more than the other reducing 
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agents, whereas it activates wild-type RCR3 less than the other reducing agents. 
Ascorbate is a mild reducing agent that is mechanistically distinct from the other 
agents. DTT and Cysteine carry sulfhydryl groups to donate hydrogen; TCEP contains 
a phosphate to accept oxygen and donate hydrogen; and ascorbate contains hydroxyl 
groups that can donate hydrogens. We were unable to find an adequate explanation 
for the effect that ascorbate has on the activity of wild-type and C224A RCR3.  
Importantly, ascorbate exists in the apoplast in millimolar concentrations (Foyer et al., 
1983). Thus the conditions tested here are physiological. 
To address the redox function further several questions should be addressed. At first it 
is necessary to identify if Cys24 is a hyper-reactive cysteine because susceptibility of 
cysteines to modifications largely depends on the characteristics of each thiol. 
Exposure and Pka play a significant role in determining cysteine reactivity. Hyper-
reactive cysteines can be identified with iodoacetate probes (Weerapana et al., 2010). 
Next we should extend this study by MS analysis of the wild-type and C24A proteins 
in the presence of ascorbate to determine modifications of Cys24. A future 3D 
structure of RCR3 will also help in deciphering the biological relevance to the extra 
cysteine. 
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CHAPTER 4: MATERIALS AND METHODS 
 
4.1 Materials 
 
4.1.1 Chemicals and Biochemicals 
All chemicals and antibiotics were supplied by Sigma (Deisenhofen, Germany), Roth 
(Karlsruhe, Germany), Merck (Darmstadt, Germany) and Duchefa (Haarlem, 
Germany). E-64, leupeptin, epoxomicin, were purchased from Sigma. All inhibitors 
were dissolved in DMSO and stored at -20 °C. BTH 50WG (Actigard/Bion, 50% 
wettable granule) was ordered from Ciba-Geigy AG. Dimethylamine-borane complex 
from Fluka (ABC). Z-Leu-Arg-AMC (Z: N-carbobenzyloxy-7-Amino-4-
methylcoumarin) was from Bachem (Germany). 
Antibodies 
Anti-FLAG M2 antibody was purchased from Sigma-Aldrich and anti-RCR3 
antibody was provided by Dr. Jonathan jones (Sainsbury laboratory, U.K). Secondary 
antibodies (HRP-conjugated anti-rabbit antibody and HRP-conjugated anti-mouse 
antibody) were purchased from Thermo Scientific.  
Enzymes 
Restriction enzymes were from Fermentas (St.Leon-Rot, Germany) and New England 
Biolabs (Frankfurt/Main, Germany). Taq polymerase for standard PCR was either 
from Promega (Mannheim, Germany) or BioBudget (Krefeld, Germany) and high-
fidelity polymerase was from Roche (Karlsruhe, Germany). Reverse-transcriptase was 
from Invitrogen (Karlsruhe, Germany). Ligases were either from Promega 
(Mannheim, Germany) or Fermentas (St.Leon-Rot, Germany). DNase and RNase 
were from Roth (Karlsruhe, Germany). 
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Activity-based probes 
Epoxide probes (DCG-04 and MV201) were provided by Dr. Herman Overkleeft 
(Leiden University, Netherlands) and Dr. Matthew Bogyo (Stanford Medical School, 
USA) and synthesized as described previously (Greenbaum et al., 2002, Richau et al., 
2012). All probes were solved in DMSO to a stock concentration of 1 mM and stored 
at -20 °C. Fluorescent probes were kept in the dark. 
Kits and primers 
Oligonucleotide primers were synthesized by Invitrogen (Karlsruhe, Germany). 
HPLC purified primers were generated by Sigma (Deisenhofen, Germany). Oligo(dT) 
primers were from Invitrogen (Karlsruhe, Germany) or Roche (Karlsruhe, Germany). 
Kits for isolating DNA or RNA were supplied from Qiagen (Hilden, Germany). 
Plasmid isolation was carried out using kits of Peqlab (Erlangen, Germany) or 
Macherey-Nagel (Duren, Germany). The Enzcheck assay kit for enzyme kinetics was 
supplied from Molecular Probes (Paisley, UK). Site-directed mutagenesis was carried 
out by Quick-change site-directed mutagenesis kit from Stratagene. Size exclusion 
chromatography was carried out by HiLoad 26/60 Superdex 75 pg prepacked column 
supplied by GE Health care. Amicon centrifugal filters (MWCO 3 kDa) from 
Millipore were used for concentrating and desalting proteins. 
All primers are listed in Table 4 at the end of the Material and Methods section. Site- 
directed mutagenesis primers are indicated in red. 
Crystallization Screens  
Standard initial crystallization screens (JCSG Core Suites (I-IV), JCSG+ Suite, 
Classics, Cryos suites, AmSO4 Suite, MPD Suite, Anion and Cation Suites and PEG 
Suites) were supplied by Qiagen.  
 
4.1.2 Biological materials 
Plant material 
Nicotiana benthamiana (310A) and tomato (Solanum lycopersicum cv. Money-
Maker) used in this work were grown at the MPIPZ (Cologne, Germany). N. 
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benthamiana and tomato were grown in a climate chamber at a 14 hour light regime 
at 22 °C (day) and 18 °C (night). Usually, 4 to 6 week-old plants were used for 
experiments. N. benthamiana leaf proteins were extracted from the agroinfiltrated 
leaves at 3 days post-infiltration (3dpi) or from fully expanded leaves of a 5 week-old 
plant. Tomato leaf proteins were extracted from the apoplast of fully expanded 
compound leaf of a 4 week-old plant. The apoplastic fluid extraction method is 
discussed in the methods section 4.2.6. 
Bacterial strains 
Escherichia coli strain DH10B and BLyS strain BL21-(DE3) F-Omp T hsdSB (rB-
mB-) Gal dcm (DE3) were used for standard cloning and protein expression 
respectively. Agrobacterium tumefaciens strain GV3101 was used for agroinfiltration 
and plant transformation. 
Yeast strains 
Pichia pastoris strain 4 (Pichiapink expression system) supplied by Invitrogen was 
used for protein expression. 
Insect strains 
Insect cell line Sf9 (Cat. No. 21300L) established from ovarian tissues of Spodoptera 
frugiperda larvae were supplied by BD Pharmingen (San Diego) for protein 
expression. 
Plasmid vectors 
The pFLAG-ATS plasmid was supplied by Sigma Aldrich. Agrobacterium carrying 
the Rcr3
pim
expression cassette with C-terminal His6 epitope tag was provided by Dr. 
Sophien Kamoun, Sainsbury laboratory, UK (Song et al., 2009) and Pichia carrying 
the expression cassette RCR3
esc 
with C-terminal His6 tag was provided by Dr. 
Boquian Wu, Carlsberg laboratory, Denmark (unpublished). pFK26, pTP25and binary 
vector pTP05 were described previously (Shabab et al., 2008). 
All collection of pathogen-derived inhibitors and proteases cloned into pFLAG-ATS 
vector for E.coli expression are listed in Table 1 (Chapter 2, section 2.1). All 
MATERIALS AND METHODS 
 
70 
 
collection of mutant RCR3 plasmids for agrobacterium mediated expression in planta 
is listed in Table 5 at the end of the Material and Methods section.  
 
4.2 Methods 
 
4.2.1 Recombinant expression and affinity purification of inhibitors and 
proteases in bacteria 
Medium 
E. coli strain BLyS (BL21-(DE3) F- omp T hsdSB (rB-mB-) Gal dcm (DE3) 
transformed with plasmid pFLAG carrying the inhibitor or protease expression 
cassette was grown overnight at 37 °C in 20 ml LB medium containing 100 μg/ml 
ampicillin. The bacterial culture was induced with 0.8 mM IPTG once the OD600 
reached 0.6 and incubated at 37 °C for 12 hr with vigorous agitation at 200 rpm on a 
shaker. The bacterial culture was centrifugated at 6000 g for 30 min with Sorvall RC-
5B centrifuge (Du Pont Instruments), and the supernatant containing secreted proteins 
was filtered through 0.22 μm filters (Steritop, Millipore). The supernatant was 
precipitated at 4°C with 95% ammonium sulphate (527.52 g/L) determined by 
http://www.encorbio.com/protocols/AM-SO4.htm. Proteins in the supernatant were 
pelleted by centrifugation at 17000 g for 45 min at 4°C and dissolved in TBS buffer 
by gentle agitation on a roller mixer (SRT2, Stuart). Proteins recovered from the 
culture supernatant were captured and purified by His6 affinity using a Poly-prep C-
column (Bio-Rad) packed with 1000 μl Nickel agarose affinity gel (Qiagen) at 4 °C. 
The column was equilibrated with two column volumes of binding buffer (50 mM 
Tris pH 7.5, 150 mM NaCl) and after passing through the protein sample, the column 
was washed three times with 2 ml binding buffer and the bound proteins were eluted 
with increasing concentrations of imidazole (gradient elution) and immediately kept 
on ice and at -80°C for long term storage. 
Soluble Cell Fraction (SCF) 
The bacterial cells expressing protease or inhibitor proteins were expressed as 
mentioned above. After induction, the bacterial culture was centrifugated at 6000 g 
for 30 minutes with Sorvall RC-5B centrifuge (Du Pont Instruments), and the 
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bacterial pellet was lysed by freeze-thaw cycles (using liquid nitrogen), lysozyme 
treatment (30 µg/ml) and sonication (branson sonifier, Germany). The lysed cell 
fraction was centrifuged at 15,000 g for 30 minutes and the soluble fraction from the 
bacterial pellet was analysed by protein blot and used for purification. 
Insoluble Cell Fraction (ICF) 
The lysed bacterial pellet was solubilised using 8M Urea in binding buffer (50 mM 
Tris pH 7.5, 150 mM NaCl). For refolding, the denatured protein was 100-fold diluted 
into the refolding buffer (50 mM Tris pH 7.5, 5 mM EDTA, 10% glycerol, 10 mM 
reduced glutathione, 1 mM oxidised glutathione and Arginine) (Kopitar et al., 1996; 
Tobbell et al., 2002; D’Alessio et al., 2002 and Hwang et al., 2002). The refolding 
procedure was performed by dialysis at 4°C for 20 hours. After dialysis, the protein 
sample was concentrated by amicon centrifugal filters and dialysed against the 
refolding buffer without the redox pair components.  
 
4.2.2 Recombinant expression and affinity purification of RCR3 in insects 
Co-transfection 
2 x 10
6
Sf9 cells were seeded onto 6 cm plates, one plate for the lipofectin transfection 
and one as a negative control. The cells were allowed to attach to the plate surface at 
27°C for 30 minutes. In the meantime the lipofectin mix (30 µl lipofectin in 1.5 ml 
IPL-41 medium w/o Fetal Calf Serum (FCS)) was added to the DNA mix (50 ng 
baculogold DNA and 1 µg transfer vector hosting the gene of interest in 1.5 ml IPL-
41 w/o FCS) and incubated at room temperature for 30 minutes. 
The medium was removed from the 6 cm plates and the cells were washed three times 
with 4 ml medium w/o FCS. 3 ml lipofectin-DNA mix was added to one plate, 3 ml 
IPL-41 w/o FCS to the negative control and both were incubated at 27°C for 5 hours. 
The supernatant was removed and the plates were washed twice with medium 
containing 5% (v/v) FCS and incubated in IPL-41 with 5% (v/v) FCS at 27°C for 5 to 
6 days. The cells were checked for infection under the microscope. Infected cells are 
larger and their nuclei are enlarged in comparison to uninfected ones. After incubation 
the supernatant was transferred into a new tube and centrifugated at 1000 g at room 
temperature for 10 minutes. The supernatant was transferred to a new tube and stored 
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at 4°C. 5 ml ice-cold PBS was added to the plate and the attached cells were removed 
with a sterile cell scraper. This suspension of cells in Phosphate Buffer Saline (PBS) 
was transferred to the cell pellet from the first centrifugation. The cells were now 
centrifuged at 1000 g at room temperature for 5 min and the pellet was resuspended in 
1 ml PBS and transferred to a microcentrifuge tube.  
Virus amplification 
1.8 x 10
6
Sf21 cells were seeded onto 25 cm
3
 tissue culture flasks. After 30 minutes 
incubation at 27°C, the medium was discarded and the cells were infected with 500 µl 
supernatant from the co-transfection. The sample as well as a negative control of cells 
in 500 µl IPL-41 with 5% (v/v) FCS were incubated at room temperature for 60 
minutes. The supernatant was removed and the incubation was continued with 5 ml 
IPL-41 with 5% (v/v) FCS at 27°C for 3 days. Cells and supernatant were harvested 
as described above. 
Intermediate stock 
5 x 10
6
Sf21 cells were seeded onto 75 cm
3
 tissue culture flasks. After 30 minutes 
incubation at 27°C, the medium was discarded and the cells were infected with 300 µl 
virus amplification supernatant and 1.2 ml IPL-41 with 5% (v/v) FCS were added. 
The sample as well as a negative control of cells in 1.5 ml IPL-41 with 5% (v/v) FCS 
were incubated at room temperature for 60 minutes. The supernatant was removed 
and the incubation was continued with 15 ml IPL-41 with 5% (v/v) FCS at 27°C for 3 
days. Cells and supernatant were harvested as described above. 
Production 
1 x 10
8
Sf21 cells were infected with 10 ml intermediate stock supernatant in a falcon 
tube. The solution was incubated at room temperature for 60 minutes. During 
infection, the tube was agitated every 15 minutes very carefully to prevent cells from 
attaching to the wall. The cells were centrifuged at 1000 rpm at room temperature for 
5 min and the supernatant was discarded. Cells were transferred with IPL-41 with 5% 
(v/v) FCS and 0.1% (w/v) Pluronic F-68 into the spinner flask and filled up to 200 ml 
with medium containing 5% (v/v) FCS and 0.1% (w/v) Pluronic F-68. The cells were 
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incubated in a spinner flask at 27°C and at 80 rpm for 3 days. The supernatant was 
harvested as described above and purified by Nickel affinity chromatography. 
 
4.2.3 Recombinant expression of proteases in yeast and affinity purification 
Pichia pastoris strain (Invitrogen) expressing full length RCR3
esc
 or  proRCR3 with 
C-terminal His6  epitope tag were grown in BMGY medium  (1% (w/v) Yeast extract, 
2% (w/v) peptone, 1.34% (w/v) yeast nitrogen base, 1% (v/v) glycerol, 100 mM 
KH2PO4, pH 6.0) for 2 days until the OD600 reaches 30-60.  After removing the cells 
by centrifugation at 1500g at room temperature, induction was inititated by 
introducing cells into the Buffered  Methanol-complex Medium (BMMY) (1% (w/v) 
yeast extract, 2% (w/v) peptone, 1.34% (w/v) yeast nitrogen base, 1% (v/v) methanol, 
100 mM KH2PO4, pH 6.0). The protein expressed in the medium was concentrated by 
amicon centrifugal filters. The tagged proteins were subsequently purified on a Ni-
NTA superflow column (Qiagen; 30430) according to the manufacturer’s protocol. 
The eluate fractions containing pure proteins were pooled. Protein concentrations 
were determined by the Bradford protein assay (Biorad).  
 
4.2.4 Activation of the proRCR3 into mature RCR3 
The proRCR3 was incubated in the presence of 100 mM NaOAc, pH 5.0 and 10 mM 
DTT for 60 – 75 minutes at 28°C. 
 
4.2.5 Agroinfiltration of Nicotiana benthamiana 
Agrobacterium tumefaciens strain GV3101 pMP90 transformed with binary vector 
containing recombinant tomato PLCP expression cassette was grown overnight at 
28°C in 10 ml LB medium containing 50 µg/ml kanamycin and 50 µg/ml rifampicin 
in a 50 ml Falcon tube. The culture was centrifuged at 3000 g for 10 minutes and the 
bacterial pellet was resuspended in 10 mM MES (pH 5), 10 mM MgCl2 and 0.2 µM 
acetosyringone to a final OD600 of 2. Agrobacterium suspensions containing binary 
PLCP expression vectors were mixed at a 1:1 ratio with Agrobacterium suspensions 
containing binary expression vector for RNA silencing inhibitor p19 (Voinnet et al., 
2003). The mixtures were kept at room temperature for 3 hours. The fully expanded 
leaves of 5 week-old N. benthamiana plants were punched with a needle and the 
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mixed Agrobacterium suspensions were infiltrated into the leaves through the needle-
holes using a 1-ml syringe (Plastipak, BD) without a needle. Leaves were harvested 
after 5 days, and the proteins from the apoplast were extracted by vacuum-mediated 
apoplastic fluid isolation. 
 
4.2.6 Apoplastic fluid isolation from Nicotiana benthamiana leaves 
Agroinfiltrated mature leaves from 5 week-old N.benthamiana plants were submerged 
into 200 ml water in a 500 ml beaker underneath a grid and a moderate weight to 
avoid up-floating of the leaves. Water was vacuum-infiltrated into N.benthamiana leaf 
apoplast by pumping out air in an exicator for 5 minutes and releasing the vacuum 
slowly. water-infiltrated leaves were dried on the surface using tissue paper and 
centrifuged at 1600 g for 10 minutes at 4°C in a tube with holes (diameter = 1 mm) in 
the bottom (generic “AF isolation device”). The AF was collected below in a larger 
collection tube. 
 
4.2.7 Quantification of protein concentration 
Protein concentrations were quantified using the Bio-Rad protein assay. In brief, 
serial dilutions of BSA standard (Promega) of 0.05-1 mg/ml were prepared, and the 
protein samples were diluted to a concentration of 0.05-1 mg/ml. 10 µl of each 
concentration standard and each protein sample were loaded into wells of a 96-well 
microtiter plate (Microtest, Falcon), and mixed with 200 µl of 1:4-diluted dye reagent 
concentrate (Bio-Rad) and incubated at room temperature for 5 minutes. The 
absorbance at 595 nm was measured with the 680 Microplate reader (Bio-Rad), and 
the concentrations of the protein samples were deduced from the standard curve made 
from the standards made with different concentrations of BSA (6.25, 12.5, 25, 50, 
100, 200, 400, 800 and 1000 µg/µl). Protein solutions were assayed in triplo. 
 
4.2.8 Site-directed mutagenesis 
Catalytic mutant proteins of RCR3, PIP1 and C14 were generated by introducing 
mutations using their parental plasmids (pSK016.01, pSK017.01, pSK018.01 and 
pSK019.01 for RCR3; pSK012.01, pSK013.01, pSK014.01 and pSK015.01 for PIP1; 
pSK009.01, pSK010.01, pSK011.01, pSK020.01, pSK021.01 and pSK022.01 for 
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C14) by using the Quick-change site-directed mutagenesis kit (Stratagene) using 
primers listed in Table 4.1. The 30-40 bp oligonucleotide primers were constructed 
such that one or two nucleotide changes result in a codon change that caused an 
amino acid substitution. Mutations were confirmed by sequencing and the confirmed 
sequence expression cassettes were shuttled into pFLAG-ATS (Sigma) or pTP5 
(Shabab et al., 2008). 
 
4.2.9 Activity-based labelling 
Tomato apoplastic proteins 
DCG-04 (MV201) labelling for 1D analysis was usually done by incubating 200-300 
μl tomato AFs in 0.5 ml reaction volume containing 25 mM NaOAc (pH 5.0), 1 mM 
DTT and 2 μM DCG-04 or MV201 for 4 hours (in the dark for MV201). All labeling 
reactions were performed at room temperature under gentle agitation on a rotator 
(STR4, Stuart). Equal volumes of DMSO were added to the no-probe-controls. 
Proteins after labelling were precipitated by adding 1 ml -20°C acetone and 
subsequent centrifugation at 16000g for 1 minute with a tabletop centrifuge (5415D, 
Eppendorf). The protein pellet was dissolved in 2x SDS-PAGE loading buffer 
containing β-mercaptoethanol, and the proteins were separated on 12% SDS PAGE 
gels at 200 V using the Novex Minicell (Invitrogen). Competition or inhibition assays 
were done by preincubating the apoplastic fluids with competitor or inhibitor 
molecules for 30 minutes before labeling with activity-based probes. 
 
4.2.10 In-gel fluorescence scanning 
SDS-PAGE gel containing fluorescent probe-labeled proteins was washed three times 
with water and labeled proteins were visualized by in-gel fluorescence scanning using 
a Typhoon 8600 scanner (Molecular Dynamics) with excitation and emission at 532 
and 580 nm, respectively. Fluorescent signals were quantified with ImageQuant 5.2 
software (Molecular Dynamics). 
 
4.2.11 Western blotting 
After SDS PAGE, proteins were transferred onto polyvinylidene fluoride membrane 
(PVDF-Immobilon-P, Millipore) at 200 mA for 60-70 minutes using X-Cell II Blot 
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Modulesystem (Invitrogen). After the transfer, the membrane was moved into a 50 ml 
Falcon tube and blocked with 5 ml of 3% BSA (Biomol) solution for 5 minutes with 
gentle agitation on a roller mixer (SRT2, Stuart). For the detection of biotinylated 
proteins, the membrane was incubated with streptavidin-HRP enzyme (Ultrasensitive, 
Sigma) at 1:3000 in the presence of 2% Tween-20 for 1 hour, and then washed five 
times with Tris-buffered-saline (TBS) (50 mM Tris 500 mM NaCl, adjust pH with 
HCl to pH 7.6) plus0.1% Tween-20 for 5 minutes each time. For the detection of 
proteins with antibodies, the membrane was incubated with the protein-specific 
primary antibody (see materials 4.1.) at 1:5000 in the presence of 2% Tween-20 for 1 
hour, and then washed 5 times with TBS buffer plus 0.1% Tween-20 for 5 minutes 
each time. Next, the membrane was incubated with HRP-conjugated anti-rabbit 
secondary antibodies (Amersham) at 1:5000 in the presence of 2% Tween-20 for 1 
hour, and then washed five times with TBS buffer plus 0.1% Tween-20 for 5 minutes 
each time. For detection, the membrane was covered with chemiluminescent 
substrates of HRP (SuperSignal West Pico/Femto, Pierce) underneath a piece of 
overhead-projection transparency, and exposed to X-ray films (BioMax MR, Kodak) 
in the darkroom. The exposed film was developed by automatic X-ray film processor 
(Optimax, Protec). 
 
4.2.12 BTH treatments 
300 μM BTH (Bion, Syngenta) was sprayed onto tomato plants with a perfume 
sprayer (Roth) to the leaf surface until the droplets ran off and the plant samples were 
harvested at day 5. 
 
4.2.13 RNA isolation, cDNA synthesis and analysis 
Total RNA was isolated from tissues frozen in liquid nitrogen using the RNeasy plant 
mini kit (QIAGEN) according to the manufacturer’s guidelines. DNase treatment was 
done before the RNA concentration was measured. cDNA was synthesised using 
Superscript II reverse transcriptase and Oligo dT primers according to the instructions 
of the manufacturer. cDNA was used as a template for PCR using primer pairs for 
gene-specific primers as summarized in Table 4.1 
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4.2.14 CD spectra 
The CD spectrum was measured on Jasco J-810 at 25˚C in a quartz cuvette. All 
spectra were corrected for buffer contributions and observed values were converted to 
molar ellipticity. Each CD spectrum was accumulated from six scans at 195-250 nm 
with a 1nm slit width and a time constant of 1s for a nominal resolution of 1nm. Far 
UV CD spectra (2 mM) were collected in the range of wavelengths of 190-250 nm 
using a cell of path length 0.1 cm for monitoring secondary structure.  
4.2.15 Fluorescence spectroscopy 
The fluorescence spectra were measured on Jasco FP-750 spectrofluorometer at 25˚C 
in a quartz cuvette. All spectra were corrected for buffer contributions. The excitation 
wavelength were 280 nm and 274 nm, the emitted fluorescence were scanned between 
290 nm to 450 nm. The protein concentration was 122 µg/ml. The samples were 
prepared in different pH buffers using Sartorius filters. 
 
4.2.16 Enzyme kinetics 
Bodipy-Casein 
Papain was pre-incubated for 30 minutes with different concentrations of AVR2 or E-
64 in the presence of 50 mM NaOAc, pH 5.0. The substrate Bodipy FL-casein ( 
Molecular Probes) was added and the activity of the enzyme was measured 
immediately. The relative amount of the released bodipy was measured every two 
minutes in a fluorescence microplate reader (Synergy4, Biotek, Germany) with 
standard fluorescein excitation filters at 485±12.5nm and emission at 530±15 nm. All 
activity measurements were performed in triplicate. 
Z-Leu-Arg-AMC (Z: N-carbobenzyloxy-7-Amino-4-methylcoumarin) 
Determination of activation of proRCR3 to mature RCR3 was measured by measuring 
the activity of the enzyme immediately after incubation with the substrate Z-Arg-
MCA ( Bachem, Germany) in the presence of 100 mM NaOAc, pH 5.0 and 10 mM 
DTT. The relative amount of the released methyl coumarin was measured in a 
fluorescence microplate reader (Synergy4, Biotek, Germany) with standard 
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fluorescein excitation filters at 380 nm and emission at 460 nm. All activity 
measurements were performed in triplicate. 
 
4.2.17 Crystallization screens 
All crystallization experiments were performed at 18˚C or 4˚C using the vapour 
diffusion method and using 100 nL of protein and different precipitant types from 
commercial screens from the Joint Centre for Structural Genomics (JCSG I-IV 
screen) and Qiagen screens including Anions, Cations, Cryos, MPD and AmSO4. The 
above screens were setup with different concentration of purified rAVR2 with and 
without epitope tags by using the automated robotic systems. 
 
4.2.18 Lysine-methylation 
The methylation reaction was performed overnight in 50 mM HEPES (pH 7.5), 250 
mM NaCl at 1 mg/ml AVR2. Twenty micro liters freshly prepared 1M 
dimethylamine-borane complex (ABC; Fluka product 15584)and 40 µl 1 M 
formaldehyde (made from 37% stock; Fluka product 33220) were added per 1 mL  of 
protein solution, and the reactions were gently mixed and incubated at 4°C for 2 
hours. After the incubation, 20 µl ABC and 40 µl formaldehyde were added and the 
incubation was continued for 2 hours. This was followed by a final addition of 10 µl 
ABC and the reaction was incubated overnight at 4°C. In some cases, the reaction 
leads to a significant amount of precipitated protein which was removed by 
centrifugation before purification of the soluble methylated protein by size-exclusion 
chromatography columns (HiLoad 26/60 Superdex 75 pg column) on Akta express 
FPLC systems; GE Healthcare and purified fractions without aggregates were 
concentrated in amicon centrifugal concentrators (Vivascience) to appropriate 
concentrations. This protocol was from Walter, 2006 derived from (Rayment, 1997; 
Rayment et al., 1993).   
 
4.2.19 Hypersensitive Response assay 
Affinity purified AVR2 was concentrated using Amicon centrifugal filter unit 
(Millipore; 3 kDa MWCO) and diluted to 1 µM final concentration in double distilled 
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water before infiltration into tomato leaves of 4-5 week old tomato plants (Cf-
2/RCR3). The plants were grown under regular greenhouse conditions to check for the 
HR response after three days post-infiltration. Buffer and water were included as 
negative controls. Other tomato genotypes (Cf-2/rcr3-3, Cf-0/rcr3-3 andCf-0/RCR3) 
were included. 
 
Table 4 List of Primers 
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1
Forward (F) and reverse primers (R); 
2 
Primer library code; 
3
Length indicated in base 
pairs 
4
 Primer sequences; mutagenesized primers are in red, mutagenesized codons are 
underlined, 
**
Primers formutagenizing agroinfiltration vectors 
 
 
 
Table 5 List of RCR3 mutant Agrobacterium constructs 
 
1
Description of the RCR3 mutant construct (C24AC25A, C24A,C25A) in the 
background of Solanum lycospersicum; 
2
Intermediate clone where the pTP 05 was 
used as shuttling vector for RCR3 mutant plasmids; 
3
Binary clone of the RCR3 
mutant plasmids using pTP05 for Agrobacterium-mediated expression. 
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